https://infectiouscongress.com 1.0 https://infectiouscongress.com/program/scientific-sessions 0.9 https://infectiouscongress.com/information/venue 0.9 https://infectiouscongress.com/information/accommodation 0.9 https://infectiouscongress.com/information/guidelines 0.9 https://infectiouscongress.com/information/faq 0.9 https://infectiouscongress.com/information/important-dates 0.9 https://infectiouscongress.com/information/conference-brochure 0.9 https://infectiouscongress.com/information/welcome-message 0.9 https://infectiouscongress.com/about/past-events 0.9 https://infectiouscongress.com/about/about-organizer 0.9 https://infectiouscongress.com/about/testimonials-reviews 0.9 https://infectiouscongress.com/contact 0.9 https://infectiouscongress.com/submit-abstract 0.9 https://infectiouscongress.com/register 0.9 https://infectiouscongress.com/general-information 0.9 https://infectiouscongress.com/privacy-policy 0.9 https://infectiouscongress.com/terms-and-conditions 0.9 https://infectiouscongress.com/cpd-accreditation 0.9 https://infectiouscongress.com/scientific-committee/2026 0.8 https://infectiouscongress.com/scientific-committee/2025 0.8 https://infectiouscongress.com/scientific-committee/2024 0.8 https://infectiouscongress.com/scientific-committee/2023 0.8 https://infectiouscongress.com/scientific-committee/2022 0.8 https://infectiouscongress.com/speakers/2026 2026-05-29 0.8 https://infectiouscongress.com/speakers/2025 0.8 https://infectiouscongress.com/speakers/2024 0.8 https://infectiouscongress.com/speakers/2023 0.8 https://infectiouscongress.com/speakers/2022 0.8 https://infectiouscongress.com/speaker/francis-j-castellino 0.8 https://infectiouscongress.com/speaker/michele-mishto 0.8 https://infectiouscongress.com/speaker/nathalie-silvestre 0.8 https://infectiouscongress.com/speaker/vincenzo-pennone 0.8 https://infectiouscongress.com/speaker/sergey-suchkov 0.8 https://infectiouscongress.com/speaker/rico-leonardo-lizbinski 0.8 https://infectiouscongress.com/speaker/anam-azhar 0.8 https://infectiouscongress.com/speaker/sasha-leibholz 0.8 https://infectiouscongress.com/speaker/lauren-gruffi 0.8 https://infectiouscongress.com/speaker/hana-raza 0.8 https://infectiouscongress.com/speaker/brooke-skinner 0.8 https://infectiouscongress.com/speaker/taylor-hermann 0.8 https://infectiouscongress.com/speaker/terri-menser 0.8 https://infectiouscongress.com/speaker/kesava-manikanta-achuta 0.8 https://infectiouscongress.com/speaker/ayana-isobe 0.8 https://infectiouscongress.com/speaker/priyanka-shekhawat 0.8 https://infectiouscongress.com/speaker/lily-zheng 0.8 https://infectiouscongress.com/speaker/brahmchetna-bedi 0.8 https://infectiouscongress.com/speaker/mila-blatz 0.8 https://infectiouscongress.com/speaker/feryal-hilmi 0.8 https://infectiouscongress.com/speaker/jenna-shoman 0.8 https://infectiouscongress.com/speaker/sarvin-youssefizad 0.8 https://infectiouscongress.com/speaker/eva-israyelyan 0.8 https://infectiouscongress.com/speaker/qian-wang 0.8 https://infectiouscongress.com/speaker/abhinav-iyer 0.8 https://infectiouscongress.com/speaker/salome-chika-igbokwe 0.8 https://infectiouscongress.com/speaker/barsha-saha 0.8 https://infectiouscongress.com/speaker/jun-zou 0.8 https://infectiouscongress.com/speaker/jodi-cooper 0.8 https://infectiouscongress.com/speaker/hannah-bray 0.8 https://infectiouscongress.com/speaker/carolyn-cross 0.8 https://infectiouscongress.com/speaker/maya-polevoi 0.8 https://infectiouscongress.com/speaker/jalees-a-nasir 0.8 https://infectiouscongress.com/speaker/smriti-chaudhary 0.8 https://infectiouscongress.com/speaker/zoya-malik 0.8 https://infectiouscongress.com/speaker/urooj-khalida-saeed 0.8 https://infectiouscongress.com/speaker/anna-fairweather 0.8 https://infectiouscongress.com/speaker/christabel-emaeyak-james 0.8 https://infectiouscongress.com/speaker/mohammed-sayeemuddin 0.8 https://infectiouscongress.com/speaker/jay-bhargav 0.8 https://infectiouscongress.com/speaker/paulo-arroyo 0.8 https://infectiouscongress.com/speaker/su-latt-paing 0.8 https://infectiouscongress.com/speaker/zara-small 0.8 https://infectiouscongress.com/speaker/em-brenner 0.8 https://infectiouscongress.com/speaker/adam-bowden 0.8 https://infectiouscongress.com/speaker/ahmad-syibli-othman 0.8 https://infectiouscongress.com/speaker/luke-perera 0.8 https://infectiouscongress.com/speaker/muhammad-zakwan-zakariya 0.8 https://infectiouscongress.com/speaker/carmel-couch 0.8 https://infectiouscongress.com/speaker/lina-awada 0.8 https://infectiouscongress.com/speaker/narjis-amar 0.8 https://infectiouscongress.com/speaker/thomas-repantis 0.8 https://infectiouscongress.com/speaker/maria-soura 0.8 https://infectiouscongress.com/speaker/christos-simoglou 0.8 https://infectiouscongress.com/speaker/panayiota-christodoulou 0.8 https://infectiouscongress.com/speaker/marios-gerou 0.8 https://infectiouscongress.com/speaker/skaiste-zukaitiene 0.8 https://infectiouscongress.com/speaker/sai-yan-pyay-aung 0.8 https://infectiouscongress.com/speaker/xin-yi-ng 0.8 https://infectiouscongress.com/speaker/nicole-freiberger 0.8 https://infectiouscongress.com/speaker/haneen-i-eldos 0.8 https://infectiouscongress.com/speaker/idessania-nazareth-costa 0.8 https://infectiouscongress.com/speaker/luiz-filippe-simao-soares 0.8 https://infectiouscongress.com/speaker/renata-zorgetti-manganaro-de-oliveira 0.8 https://infectiouscongress.com/speaker/lucas-granja-cotrik 0.8 https://infectiouscongress.com/speaker/bruna-barros-da-fonseca 0.8 https://infectiouscongress.com/speaker/nilton-gabriel-vicente-fernandes-da-silva 0.8 https://infectiouscongress.com/speaker/bruna-dos-santos-costa 0.8 https://infectiouscongress.com/speaker/barbara-alves-rhomberg 0.8 https://infectiouscongress.com/speaker/eliana-guedes-stehling 0.8 https://infectiouscongress.com/speaker/rebeca-dall-aqua-de-godoy 0.8 https://infectiouscongress.com/speaker/gustavo-gomedi 0.8 https://infectiouscongress.com/speaker/camila-amormino-corsini 0.8 https://infectiouscongress.com/speaker/robson-amaro-augusto-da-silva 0.8 https://infectiouscongress.com/speaker/yolanda-prado 0.8 https://infectiouscongress.com/speaker/elmira-rastyamovna-samitova 0.8 https://infectiouscongress.com/speaker/lyashuk-safiya 0.8 https://infectiouscongress.com/speaker/jin-hur 0.8 https://infectiouscongress.com/speaker/jong-hoon-kim 0.8 https://infectiouscongress.com/speaker/chihang-chang 0.8 https://infectiouscongress.com/speaker/yucheng-lin 0.8 https://infectiouscongress.com/speaker/chun-hsiang-chiu 0.8 https://infectiouscongress.com/speaker/mallak-alnaabi 0.8 https://infectiouscongress.com/speaker/hade-ramos 0.8 https://infectiouscongress.com/speaker/hatice-ceylan 0.8 https://infectiouscongress.com/speaker/simoiu-madalina 0.8 https://infectiouscongress.com/speaker/maria-alejandra-vethencourt-ysea 0.8 https://infectiouscongress.com/speaker/sergio-silvestre-soto-sanchez 0.8 https://infectiouscongress.com/speaker/fernanda-de-blas-lopez 0.8 https://infectiouscongress.com/speaker/yaira-eloisa-mendoza-montijo 0.8 https://infectiouscongress.com/speaker/darehyne-avila-pina 0.8 https://infectiouscongress.com/speaker/enerik 0.8 https://infectiouscongress.com/speaker/ermira-muco 0.8 https://infectiouscongress.com/speaker/neada-hoxha 0.8 https://infectiouscongress.com/speaker/xueli-zheng 0.8 https://infectiouscongress.com/speaker/ali-hassan-gillani 0.8 https://infectiouscongress.com/speaker/yuxi-liu 0.8 https://infectiouscongress.com/speaker/yongfeng-yang 0.8 https://infectiouscongress.com/speaker/yacob-mathai-kunnathazhath 0.8 https://infectiouscongress.com/speaker/arnab-roy 0.8 https://infectiouscongress.com/speaker/ambati-mrudula-srinivasulu 0.8 https://infectiouscongress.com/speaker/barsha-mohanty 0.8 https://infectiouscongress.com/speaker/kunalsen-jagatdeo 0.8 https://infectiouscongress.com/speaker/abhipsha-anuranjana 0.8 https://infectiouscongress.com/speaker/suraj-chandrabhan-singh 0.8 https://infectiouscongress.com/speaker/abhishek-kandikatla 0.8 https://infectiouscongress.com/speaker/mariyah-yousuf 0.8 https://infectiouscongress.com/speaker/priya-vadivel-sreenivasan 0.8 https://infectiouscongress.com/speaker/ambreen-sultana 0.8 https://infectiouscongress.com/speaker/hariharan-s-naidu 0.8 https://infectiouscongress.com/speaker/navanitha-chandrasekaran 0.8 https://infectiouscongress.com/speaker/percival-c-dilla 0.8 https://infectiouscongress.com/speaker/ray-john-m-salud 0.8 https://infectiouscongress.com/speaker/devin-edjohn-michael-aballe 0.8 https://infectiouscongress.com/speaker/carmela-bianca-villacete 0.8 https://infectiouscongress.com/speaker/cinderella-gerna 0.8 https://infectiouscongress.com/speaker/jozen-ray-dragon 0.8 https://infectiouscongress.com/speaker/lotgarda-tayao 0.8 https://infectiouscongress.com/speaker/samuel-ayo 0.8 https://infectiouscongress.com/speaker/sharrah-mae-tan 0.8 https://infectiouscongress.com/speaker/john-luis-wee 0.8 https://infectiouscongress.com/speaker/kate-cassandra-digaum 0.8 https://infectiouscongress.com/speaker/desiree-sor-mejica 0.8 https://infectiouscongress.com/speaker/john-matthew-s-tan 0.8 https://infectiouscongress.com/speaker/dulce-gregorio-talavera 0.8 https://infectiouscongress.com/speaker/beatricia-alyssandra-lat-luceno 0.8 https://infectiouscongress.com/speaker/thi-hong-hai-phan 0.8 https://infectiouscongress.com/speaker/khaled-waleed-salama-hemdan 0.8 https://infectiouscongress.com/speaker/carlos-yesid-soto-ospina 0.8 https://infectiouscongress.com/speaker/andres-alejandro-rodriguez-bobadilla 0.8 https://infectiouscongress.com/speaker/laura-camila-caceres-delgado 0.8 https://infectiouscongress.com/speaker/yurdey-fernanda-herran-murillo 0.8 https://infectiouscongress.com/speaker/safia-chaabi 0.8 https://infectiouscongress.com/speaker/chaimae-chiguer 0.8 https://infectiouscongress.com/speaker/naylya-djumaeva 0.8 https://infectiouscongress.com/speaker/tawakalit-olubukola-salam 0.8 https://infectiouscongress.com/speaker/amanda-fox 0.8 https://infectiouscongress.com/speaker/george-riding 0.8 https://infectiouscongress.com/speaker/panova-yuliya 0.8 https://infectiouscongress.com/speaker/zeynep-burcin-yilmaz 0.8 https://infectiouscongress.com/speaker/geoffrey-nwaka 0.8 https://infectiouscongress.com/speaker/sushmita-das 0.8 https://infectiouscongress.com/speaker/yazdan-mirzanejad 0.8 https://infectiouscongress.com/speaker/pio-conti 0.8 https://infectiouscongress.com/speaker/elena-chiappini 0.8 https://infectiouscongress.com/speaker/dong-h-kwon 0.8 https://infectiouscongress.com/speaker/nadine-rouphael 0.8 https://infectiouscongress.com/speaker/debra-hawkins 0.8 https://infectiouscongress.com/speaker/dongming-li 0.8 https://infectiouscongress.com/speaker/thomas-cirrito 0.8 https://infectiouscongress.com/speaker/shree-govani 0.8 https://infectiouscongress.com/speaker/raymond-anthony 0.8 https://infectiouscongress.com/speaker/swapna-sirigireddy 0.8 https://infectiouscongress.com/speaker/lee-fuller 0.8 https://infectiouscongress.com/speaker/alexia-gordon 0.8 https://infectiouscongress.com/speaker/komal-romance 0.8 https://infectiouscongress.com/speaker/erin-sarah-honsa 0.8 https://infectiouscongress.com/speaker/symonne-liu 0.8 https://infectiouscongress.com/speaker/simon-berthelot 0.8 https://infectiouscongress.com/speaker/mortaza-baky-haskuee 0.8 https://infectiouscongress.com/speaker/nicole-azizeh 0.8 https://infectiouscongress.com/speaker/saoirse-coyne 0.8 https://infectiouscongress.com/speaker/mariam-abu-jubain 0.8 https://infectiouscongress.com/speaker/himanshu-gul-mirani 0.8 https://infectiouscongress.com/speaker/jasmine-buck 0.8 https://infectiouscongress.com/speaker/aissar-abou-trabeh 0.8 https://infectiouscongress.com/speaker/amani-mokbel 0.8 https://infectiouscongress.com/speaker/hira-ghuman 0.8 https://infectiouscongress.com/speaker/sanchutha-sathiananthamoorthy 0.8 https://infectiouscongress.com/speaker/emma-johnston 0.8 https://infectiouscongress.com/speaker/jonathan-mcintosh 0.8 https://infectiouscongress.com/speaker/waleed-zahoor-bandey 0.8 https://infectiouscongress.com/speaker/sowmitra-das 0.8 https://infectiouscongress.com/speaker/anika-tabassum 0.8 https://infectiouscongress.com/speaker/orkun-kaymaz 0.8 https://infectiouscongress.com/speaker/syeda-tanjina-rashid-tamanna 0.8 https://infectiouscongress.com/speaker/thomas-swift 0.8 https://infectiouscongress.com/speaker/elsa-brigitte-phillips 0.8 https://infectiouscongress.com/speaker/brielle-jasmine-smidt-wallis 0.8 https://infectiouscongress.com/speaker/amy-udall 0.8 https://infectiouscongress.com/speaker/joanne-m-mushi 0.8 https://infectiouscongress.com/speaker/charlotte-a-hoy 0.8 https://infectiouscongress.com/speaker/ozge-ozturk 0.8 https://infectiouscongress.com/speaker/edmund-ong 0.8 https://infectiouscongress.com/speaker/kurt-e-muller 0.8 https://infectiouscongress.com/speaker/fawzy-abdelatty 0.8 https://infectiouscongress.com/speaker/chengjun-jin 0.8 https://infectiouscongress.com/speaker/kamila-sfugier-tollik 0.8 https://infectiouscongress.com/speaker/emanuela-ruggiero 0.8 https://infectiouscongress.com/speaker/chiara-romano 0.8 https://infectiouscongress.com/speaker/zbigniew-dzialanski 0.8 https://infectiouscongress.com/speaker/mohammed-ghalib-enayathullah 0.8 https://infectiouscongress.com/speaker/antonella-cardone 0.8 https://infectiouscongress.com/speaker/graham-betts-symonds 0.8 https://infectiouscongress.com/speaker/romana-moutelikova 0.8 https://infectiouscongress.com/speaker/daniel-s-bednarik 0.8 https://infectiouscongress.com/speaker/hadj-mehdi-hiba 0.8 https://infectiouscongress.com/speaker/lidia-sierpinska 0.8 https://infectiouscongress.com/speaker/victoria-de-lima-burnier 0.8 https://infectiouscongress.com/speaker/cl-udio-tadeu-daniel-ribeiro 0.8 https://infectiouscongress.com/speaker/andreia-de-paula-vieira 0.8 https://infectiouscongress.com/speaker/ronaldo-zucatelli-mendonca 0.8 https://infectiouscongress.com/speaker/maria-carolina-neri-martins 0.8 https://infectiouscongress.com/speaker/roman-kozlov 0.8 https://infectiouscongress.com/speaker/sung-wook-song 0.8 https://infectiouscongress.com/speaker/wooseong-jeong 0.8 https://infectiouscongress.com/speaker/jeong-rae-yoo 0.8 https://infectiouscongress.com/speaker/hye-ji-yang 0.8 https://infectiouscongress.com/speaker/ahreum-park 0.8 https://infectiouscongress.com/speaker/cheung-yuk-yam 0.8 https://infectiouscongress.com/speaker/shahd-mufid-a-mohammad 0.8 https://infectiouscongress.com/speaker/susu-zughaier 0.8 https://infectiouscongress.com/speaker/hamda-al-mansoori 0.8 https://infectiouscongress.com/speaker/roberto-bobadilla-fazzini 0.8 https://infectiouscongress.com/speaker/sara-mohammed-ahmed-rady 0.8 https://infectiouscongress.com/speaker/ilayda-erakin-kaya 0.8 https://infectiouscongress.com/speaker/indries-mirela 0.8 https://infectiouscongress.com/speaker/silviya-stoyanova 0.8 https://infectiouscongress.com/speaker/haydee-torres-guerrero 0.8 https://infectiouscongress.com/speaker/susana-mendoza 0.8 https://infectiouscongress.com/speaker/laura-hernandez-andrade 0.8 https://infectiouscongress.com/speaker/jose-agustin-carrillo-rodriguez 0.8 https://infectiouscongress.com/speaker/eriko-padron-regalado 0.8 https://infectiouscongress.com/speaker/maria-antonieta-quispe-ricalde 0.8 https://infectiouscongress.com/speaker/susan-espetia-anco 0.8 https://infectiouscongress.com/speaker/iva-rrugia 0.8 https://infectiouscongress.com/speaker/seema-nabil-nimer 0.8 https://infectiouscongress.com/speaker/zhexi-lv 0.8 https://infectiouscongress.com/speaker/jintang-he 0.8 https://infectiouscongress.com/speaker/yuan-fang 0.8 https://infectiouscongress.com/speaker/chuanshan-zhang 0.8 https://infectiouscongress.com/speaker/fusen-lin 0.8 https://infectiouscongress.com/speaker/ashvini-gupta 0.8 https://infectiouscongress.com/speaker/erin-liz-john 0.8 https://infectiouscongress.com/speaker/rachna-rohilla 0.8 https://infectiouscongress.com/speaker/nikrish-s-hegde 0.8 https://infectiouscongress.com/speaker/goutham-krishna 0.8 https://infectiouscongress.com/speaker/danish-e 0.8 https://infectiouscongress.com/speaker/pallab-kumar-sinha 0.8 https://infectiouscongress.com/speaker/swati-kumari 0.8 https://infectiouscongress.com/speaker/manisha-bais-thakur 0.8 https://infectiouscongress.com/speaker/suryawanshi-hrishikesh-krishnahari 0.8 https://infectiouscongress.com/speaker/shova-shrestha 0.8 https://infectiouscongress.com/speaker/siwimol-phoomniyom 0.8 https://infectiouscongress.com/speaker/yvanne-joshua-c-rabe 0.8 https://infectiouscongress.com/speaker/kimberly-may-perez-borja 0.8 https://infectiouscongress.com/speaker/velma-herwanto 0.8 https://infectiouscongress.com/speaker/u-a-w-l-perera 0.8 https://infectiouscongress.com/speaker/shostakovych-koretska-liudmyla 0.8 https://infectiouscongress.com/speaker/manuel-antonio-sierra-santos 0.8 https://infectiouscongress.com/speaker/mahdieh-sorouri-majd 0.8 https://infectiouscongress.com/speaker/succes-bouangui-bazolana 0.8 https://infectiouscongress.com/speaker/kalilu-samuka-donzo 0.8 https://infectiouscongress.com/speaker/james-kinoti-njue 0.8 https://infectiouscongress.com/speaker/nicholas-svitek 0.8 https://infectiouscongress.com/speaker/kinta-a-alexander 0.8 https://infectiouscongress.com/speaker/meerab-fatima 0.8 https://infectiouscongress.com/speaker/myra-tariq 0.8 https://infectiouscongress.com/speaker/eun-jung-choi 0.8 https://infectiouscongress.com/speaker/jiancheng-qi 0.8 https://infectiouscongress.com/speaker/zongxing-zhang 0.8 https://infectiouscongress.com/speaker/abraham-p-bayan 0.8 https://infectiouscongress.com/speaker/julianne-marie-s-amojedo 0.8 https://infectiouscongress.com/speaker/soukaina-mounsif 0.8 https://infectiouscongress.com/speaker/charles-kwobah 0.8 https://infectiouscongress.com/speaker/fjorda-berisha 0.8 https://infectiouscongress.com/speaker/hien-yeri-esther 0.8 https://infectiouscongress.com/speaker/siham-mahgoub 0.8 https://infectiouscongress.com/speaker/zhang-yi 0.8 https://infectiouscongress.com/speaker/sara-omar-swar 0.8 https://infectiouscongress.com/speaker/alina-elena-ivanciuc 0.8 https://infectiouscongress.com/speaker/sadia-faisal 0.8 https://infectiouscongress.com/speaker/reza-nassiri 0.8 https://infectiouscongress.com/speaker/daniel-a-lichtenstein 0.8 https://infectiouscongress.com/speaker/krzysztof-skowron 0.8 https://infectiouscongress.com/speaker/ashin-mehta 0.8 https://infectiouscongress.com/speaker/michele-de-leon-jauregui 0.8 https://infectiouscongress.com/speaker/melanie-rosado 0.8 https://infectiouscongress.com/speaker/nikki-kasal 0.8 https://infectiouscongress.com/speaker/susannah-colt 0.8 https://infectiouscongress.com/speaker/aung-sitt-naing 0.8 https://infectiouscongress.com/speaker/ashley-zhou 0.8 https://infectiouscongress.com/speaker/arjun-chadha 0.8 https://infectiouscongress.com/speaker/julissa-soto 0.8 https://infectiouscongress.com/speaker/david-stiles 0.8 https://infectiouscongress.com/speaker/lauren-panny 0.8 https://infectiouscongress.com/speaker/eric-brownhill 0.8 https://infectiouscongress.com/speaker/sneha-thatipelli 0.8 https://infectiouscongress.com/speaker/jonathan-lambo 0.8 https://infectiouscongress.com/speaker/kathleen-maguire 0.8 https://infectiouscongress.com/speaker/elizabeth-yvonne-flores 0.8 https://infectiouscongress.com/speaker/prabha-chandrasekaran 0.8 https://infectiouscongress.com/speaker/fiona-murphy 0.8 https://infectiouscongress.com/speaker/franciela-golden 0.8 https://infectiouscongress.com/speaker/yuhang-liu 0.8 https://infectiouscongress.com/speaker/lauren-middlebrooks 0.8 https://infectiouscongress.com/speaker/netty-santoso 0.8 https://infectiouscongress.com/speaker/aaron-briggs 0.8 https://infectiouscongress.com/speaker/maria-aguilar-amaya 0.8 https://infectiouscongress.com/speaker/yuanbin-wang 0.8 https://infectiouscongress.com/speaker/cara-spence 0.8 https://infectiouscongress.com/speaker/alexis-torres-rodriguez 0.8 https://infectiouscongress.com/speaker/angelica-ludena 0.8 https://infectiouscongress.com/speaker/caroline-ballet 0.8 https://infectiouscongress.com/speaker/valerie-pourcher 0.8 https://infectiouscongress.com/speaker/claudia-ferreira 0.8 https://infectiouscongress.com/speaker/amy-hesketh 0.8 https://infectiouscongress.com/speaker/katarzyna-grudlewska-buda 0.8 https://infectiouscongress.com/speaker/joo-hee-waelzlein 0.8 https://infectiouscongress.com/speaker/daniela-tirotta 0.8 https://infectiouscongress.com/speaker/andreas-christodoulou 0.8 https://infectiouscongress.com/speaker/pedro-plans-rubio 0.8 https://infectiouscongress.com/speaker/tania-ayllon-santiago 0.8 https://infectiouscongress.com/speaker/pere-domingo-pedrol 0.8 https://infectiouscongress.com/speaker/anne-morris 0.8 https://infectiouscongress.com/speaker/hamza-rashid 0.8 https://infectiouscongress.com/speaker/keekok-lee 0.8 https://infectiouscongress.com/speaker/amitabha-majumdar 0.8 https://infectiouscongress.com/speaker/ahmed-abdalla 0.8 https://infectiouscongress.com/speaker/dorarca-lynch 0.8 https://infectiouscongress.com/speaker/julia-nowak 0.8 https://infectiouscongress.com/speaker/david-geiner-mejia-zavala 0.8 https://infectiouscongress.com/speaker/ahmed-esam-mahboub 0.8 https://infectiouscongress.com/speaker/ahmad-subhi 0.8 https://infectiouscongress.com/speaker/reem-alblooshi 0.8 https://infectiouscongress.com/speaker/reem-abdulla-alsaadi 0.8 https://infectiouscongress.com/speaker/nawal-alkaabi 0.8 https://infectiouscongress.com/speaker/ahsan-ehtesham 0.8 https://infectiouscongress.com/speaker/anastasiia-panova 0.8 https://infectiouscongress.com/speaker/saliha-gokce-alagoz 0.8 https://infectiouscongress.com/speaker/hatice-turk-dagi 0.8 https://infectiouscongress.com/speaker/elucir-gir 0.8 https://infectiouscongress.com/speaker/renata-karina-reis 0.8 https://infectiouscongress.com/speaker/eduardo-ferracioli-oda 0.8 https://infectiouscongress.com/speaker/nicole-abdullah 0.8 https://infectiouscongress.com/speaker/francisco-borges-costa 0.8 https://infectiouscongress.com/speaker/camila-melo-de-freitas 0.8 https://infectiouscongress.com/speaker/laura-fermiano-bastos 0.8 https://infectiouscongress.com/speaker/ihtisham-ul-haq 0.8 https://infectiouscongress.com/speaker/simona-yoffe-deri 0.8 https://infectiouscongress.com/speaker/filipa-de-aragao 0.8 https://infectiouscongress.com/speaker/silvia-giono-cerezo 0.8 https://infectiouscongress.com/speaker/luis-felipe-vargas-garcia 0.8 https://infectiouscongress.com/speaker/preslava-hristova 0.8 https://infectiouscongress.com/speaker/petersian-m-alcazaren 0.8 https://infectiouscongress.com/speaker/nadine-bacalangco-suerte 0.8 https://infectiouscongress.com/speaker/kristine-mae-d-barredo 0.8 https://infectiouscongress.com/speaker/quennie-bien-bien-c-yu 0.8 https://infectiouscongress.com/speaker/ro-janna-jamahari-jamiri-sarapuddin 0.8 https://infectiouscongress.com/speaker/karen-ivy-bacsain 0.8 https://infectiouscongress.com/speaker/edeline-anne-dondonilla 0.8 https://infectiouscongress.com/speaker/hideliz-marie-g-pascua 0.8 https://infectiouscongress.com/speaker/sinisa-skocibusic 0.8 https://infectiouscongress.com/speaker/filip-razga 0.8 https://infectiouscongress.com/speaker/veronika-nemethova 0.8 https://infectiouscongress.com/speaker/xiaoyun-zhao 0.8 https://infectiouscongress.com/speaker/xiaohua-li 0.8 https://infectiouscongress.com/speaker/dong-hyun-kim 0.8 https://infectiouscongress.com/speaker/tran-lam-tu-quyen 0.8 https://infectiouscongress.com/speaker/yen-chin-liu 0.8 https://infectiouscongress.com/speaker/sukki-ho 0.8 https://infectiouscongress.com/speaker/aji-antony 0.8 https://infectiouscongress.com/speaker/anil-budania 0.8 https://infectiouscongress.com/speaker/anupma-harshal-w 0.8 https://infectiouscongress.com/speaker/himani-agri 0.8 https://infectiouscongress.com/speaker/aparna-m-menon 0.8 https://infectiouscongress.com/speaker/shweta-chelluboina 0.8 https://infectiouscongress.com/speaker/vineeta-arora 0.8 https://infectiouscongress.com/speaker/rosshini-kummararaj 0.8 https://infectiouscongress.com/speaker/dian-wulandaru-sukmaning-pertiwi 0.8 https://infectiouscongress.com/speaker/jusup-andi-purwanto 0.8 https://infectiouscongress.com/speaker/niranjan-nayak 0.8 https://infectiouscongress.com/speaker/muhammad-amjad-khan 0.8 https://infectiouscongress.com/speaker/komal-mushtaq 0.8 https://infectiouscongress.com/speaker/comfort-oluladun-aiki-raji 0.8 https://infectiouscongress.com/speaker/helmi-ernandes 0.8 https://infectiouscongress.com/speaker/lilishia-gounder 0.8 https://infectiouscongress.com/speaker/patrone-rebecca-risenga 0.8 https://infectiouscongress.com/speaker/alvaro-j-vivas-salinas 0.8 https://infectiouscongress.com/speaker/sira-s-owibingire 0.8 https://infectiouscongress.com/speaker/demboux-lyelet-jordy-exauce 0.8 https://infectiouscongress.com/speaker/parvin-dehghan 0.8 https://infectiouscongress.com/speaker/andrew-kimera 0.8 https://infectiouscongress.com/speaker/khalid-muneer-albalushi 0.8 https://infectiouscongress.com/speaker/elinam-adzo-agbobli 0.8 https://infectiouscongress.com/speaker/maria-de-fatima-ferreira-da-cruz 0.8 https://infectiouscongress.com/speaker/dongsheng-jiang 0.8 https://infectiouscongress.com/speaker/nouf-alaboud 0.8 https://infectiouscongress.com/speaker/britt-hornei 0.8 https://infectiouscongress.com/speaker/ranjan-ramasamy 0.8 https://infectiouscongress.com/speaker/saurabh-chattopadhyay 0.8 https://infectiouscongress.com/speaker/mohammad-mir 0.8 https://infectiouscongress.com/speaker/sheema-mir 0.8 https://infectiouscongress.com/speaker/brandon-lucke-wold 0.8 https://infectiouscongress.com/speaker/tafaani-khan 0.8 https://infectiouscongress.com/speaker/walter-fabricio-silva-martins 0.8 https://infectiouscongress.com/speaker/marina-nick 0.8 https://infectiouscongress.com/speaker/matthew-emmerson 0.8 https://infectiouscongress.com/speaker/tharanika-ahillan 0.8 https://infectiouscongress.com/speaker/dharanga-rumeshi-ratnayake 0.8 https://infectiouscongress.com/speaker/michael-ansah 0.8 https://infectiouscongress.com/speaker/sheeba-s-sawant 0.8 https://infectiouscongress.com/speaker/jaime-david-acosta-espana 0.8 https://infectiouscongress.com/speaker/kathrin-weyer 0.8 https://infectiouscongress.com/speaker/giuseppe-joe-vincini 0.8 https://infectiouscongress.com/speaker/nai-an-lai 0.8 https://infectiouscongress.com/speaker/wayne-joseph-dimech 0.8 https://infectiouscongress.com/speaker/rickyle-christopher-balea 0.8 https://infectiouscongress.com/speaker/susan-jack 0.8 https://infectiouscongress.com/speaker/genevieve-inchauspe 0.8 https://infectiouscongress.com/speaker/pietro-salvatori 0.8 https://infectiouscongress.com/speaker/alfonso-recordare 0.8 https://infectiouscongress.com/speaker/sara-sentre-domingo 0.8 https://infectiouscongress.com/speaker/alfredo-berzal-herranz 0.8 https://infectiouscongress.com/speaker/m-esperanza-teresa-rodrigo 0.8 https://infectiouscongress.com/speaker/cintia-gisela-cevallos 0.8 https://infectiouscongress.com/speaker/victoria-belen-ayala-pena 0.8 https://infectiouscongress.com/speaker/hany-sady-shokry-redah 0.8 https://infectiouscongress.com/speaker/mustafa-akin 0.8 https://infectiouscongress.com/speaker/jacek-z-kubiak 0.8 https://infectiouscongress.com/speaker/masafumi-seki 0.8 https://infectiouscongress.com/speaker/jernell-robert-d-malixi 0.8 https://infectiouscongress.com/speaker/maria-yvez-erika-p-ugale 0.8 https://infectiouscongress.com/speaker/diana-gonzaga-ramos 0.8 https://infectiouscongress.com/speaker/philip-john-m-joves 0.8 https://infectiouscongress.com/speaker/armin-mehmedovic 0.8 https://infectiouscongress.com/speaker/magdalena-piatek 0.8 https://infectiouscongress.com/speaker/ratna-ayu-cahaya-kusuma-dewi 0.8 https://infectiouscongress.com/speaker/elfian-rachmawati 0.8 https://infectiouscongress.com/speaker/ivelina-trifonova-trionova 0.8 https://infectiouscongress.com/speaker/georgios-d-theodorakopoulos 0.8 https://infectiouscongress.com/speaker/saleh-binmahfooz 0.8 https://infectiouscongress.com/speaker/mohammad-alshomrani 0.8 https://infectiouscongress.com/speaker/mohsin-khared 0.8 https://infectiouscongress.com/speaker/vijay-prabha 0.8 https://infectiouscongress.com/speaker/kushal-kalvit 0.8 https://infectiouscongress.com/speaker/saiema-ahmedi 0.8 https://infectiouscongress.com/speaker/preeti-chaudhary 0.8 https://infectiouscongress.com/speaker/m-nika-madai 0.8 https://infectiouscongress.com/speaker/rege-anna-marton 0.8 https://infectiouscongress.com/speaker/zsaklin-varga 0.8 https://infectiouscongress.com/speaker/raquel-gardini-sanches-palasio 0.8 https://infectiouscongress.com/speaker/patricia-marques-moralejo-bermudi 0.8 https://infectiouscongress.com/speaker/kristina-cerniauskiene 0.8 https://infectiouscongress.com/speaker/milda-pleckaityte 0.8 https://infectiouscongress.com/speaker/aurelija-zvirbliene 0.8 https://infectiouscongress.com/speaker/yuying-tang 0.8 https://infectiouscongress.com/speaker/chunyang-li 0.8 https://infectiouscongress.com/speaker/yuefeng-song 0.8 https://infectiouscongress.com/speaker/shuyun-liu 0.8 https://infectiouscongress.com/speaker/wenmei-wang 0.8 https://infectiouscongress.com/speaker/jieming-qu 0.8 https://infectiouscongress.com/speaker/waqar-ahmad 0.8 https://infectiouscongress.com/speaker/khalid-abd-elghany 0.8 https://infectiouscongress.com/speaker/jeng-how-yang 0.8 https://infectiouscongress.com/speaker/klemen-bohinc 0.8 https://infectiouscongress.com/speaker/vladimir-zajac 0.8 https://infectiouscongress.com/speaker/elena-hatalova 0.8 https://infectiouscongress.com/speaker/houda-limam 0.8 https://infectiouscongress.com/speaker/mohammad-al-mamun 0.8 https://infectiouscongress.com/speaker/bidhi-dhital 0.8 https://infectiouscongress.com/speaker/adela-ngwewondo 0.8 https://infectiouscongress.com/speaker/marwah-saud-al-thuhli 0.8 https://infectiouscongress.com/speaker/aws-sami-sulaiman-al-farsi 0.8 https://infectiouscongress.com/speaker/emmanuel-boafo 0.8 https://infectiouscongress.com/speaker/fejiro-chinye-nwoko 0.8 https://infectiouscongress.com/speaker/ahlam-abdulsalam-albahloul-almabrouk 0.8 https://infectiouscongress.com/speaker/gadissa-bedada-hundie 0.8 https://infectiouscongress.com/speaker/anderson-da-silva-r-go 0.8 https://infectiouscongress.com/speaker/isra-mufadal-abdulkareem-abdullah-bur 0.8 https://infectiouscongress.com/speaker/clara-fehrmann 0.8 https://infectiouscongress.com/speaker/agnes-nagy 0.8 https://infectiouscongress.com/speaker/jairo-antonio-cardenas-londono 0.8 https://infectiouscongress.com/speaker/rachida-belhadj-aissa 0.8 https://infectiouscongress.com/speaker/rajaa-sulaiman-al-aamri 0.8 https://infectiouscongress.com/speaker/huiyi-feng 0.8 https://infectiouscongress.com/speaker/weixi-shen 0.8 https://infectiouscongress.com/speaker/chansay-pathammavong 0.8 https://infectiouscongress.com/speaker/katerina-mitsakos 0.8 https://infectiouscongress.com/speaker/abdallah-musa-abdallah 0.8 https://infectiouscongress.com/speaker/sisay-shewasinad-yehualashet 0.8 https://infectiouscongress.com/speaker/ulrich-steinhoff 0.8 https://infectiouscongress.com/speaker/maria-teresa-rosanova 0.8 https://infectiouscongress.com/speaker/stephen-hsu 0.8 https://infectiouscongress.com/speaker/lester-jay-t-corsame 0.8 https://infectiouscongress.com/speaker/mvz-juan-ignacio-tamayo-basurto 0.8 https://infectiouscongress.com/speaker/hector-javier-gallardo-valencia 0.8 https://infectiouscongress.com/speaker/asit-kumar-chakraborty 0.8 https://infectiouscongress.com/speaker/anapurna-ahuja 0.8 https://infectiouscongress.com/speaker/gayatri-tripathi 0.8 https://infectiouscongress.com/speaker/mohamad-said-almasri 0.8 https://infectiouscongress.com/speaker/mehdi-fatahi-bafghi 0.8 https://infectiouscongress.com/speaker/balamurugan-r 0.8 https://infectiouscongress.com/speaker/yanelis-cruz-santana 0.8 https://infectiouscongress.com/speaker/rohit-kothari 0.8 https://infectiouscongress.com/speaker/j-a-a-s-jayaweea 0.8 https://infectiouscongress.com/speaker/pooyan-afzali-harsini 0.8 https://infectiouscongress.com/speaker/rene-a-amadore 0.8 https://infectiouscongress.com/speaker/marshal-sikandangwa 0.8 https://infectiouscongress.com/speaker/dimple-sethi-chopra 0.8 https://infectiouscongress.com/speaker/amit-kumar-kesharwani 0.8 https://infectiouscongress.com/speaker/maureen-akolo 0.8 https://infectiouscongress.com/speaker/hamideh-abbaspour 0.8 https://infectiouscongress.com/speaker/sayan-bhattacharyya 0.8 https://infectiouscongress.com/speaker/ambresh-s-badad 0.8 https://infectiouscongress.com/speaker/amarjeet-gambhir 0.8 https://infectiouscongress.com/speaker/jiarong-zhong 0.8 https://infectiouscongress.com/speaker/kai-fu-tang 0.8 https://infectiouscongress.com/speaker/ricardo-oses-rodriguez 0.8 https://infectiouscongress.com/speaker/anju-kaushal 0.8 https://infectiouscongress.com/speaker/ariadna-martinez-oquendo 0.8 https://infectiouscongress.com/speaker/grace-lalana-christopher 0.8 https://infectiouscongress.com/speaker/amanda-henriques-cavalheiro 0.8 https://infectiouscongress.com/speaker/marah-el-tahir-el-beeli 0.8 https://infectiouscongress.com/speaker/rehab-mahmoud-abd-el-baky 0.8 https://infectiouscongress.com/speaker/shyamapada-mandal 0.8 https://infectiouscongress.com/speaker/abdullah-ali-abdullah-gafer 0.8 https://infectiouscongress.com/speaker/asmaa-al-rashed 0.8 https://infectiouscongress.com/speaker/taif-shah 0.8 https://infectiouscongress.com/speaker/seema-mittal 0.8 https://infectiouscongress.com/speaker/ghazala-rubi 0.8 https://infectiouscongress.com/speaker/jaylo-garcia-abalos 0.8 https://infectiouscongress.com/speaker/bayuh-asmamaw-hailu 0.8 https://infectiouscongress.com/speaker/anas-alyousef 0.8 https://infectiouscongress.com/speaker/nashwa-elsayed-elkasaby 0.8 https://infectiouscongress.com/speaker/nadhem-selmi 0.8 https://infectiouscongress.com/speaker/wei-jiang 0.8 https://infectiouscongress.com/speaker/mouna-jlidi 0.8 https://infectiouscongress.com/program/scientific-program/2026 2026-05-29 0.8 https://infectiouscongress.com/program/scientific-program/2025 0.8 https://infectiouscongress.com/program/scientific-program/2024 0.8 https://infectiouscongress.com/program/scientific-program/2023 0.8 https://infectiouscongress.com/program/scientific-program/2022 0.8 https://infectiouscongress.com/program/scientific-program/2026/changing-population-immunity-to-covid-19-in-the-context-of-infection-vaccination-and-emerging-sars-cov-2-variants 0.8 https://infectiouscongress.com/program/scientific-program/2026/extensively-drug-resistant-bacterial-infections-confronting-a-global-crisis-with-urgent-solutions-in-prevention-surveillance-and-treatment 0.8 https://infectiouscongress.com/program/scientific-program/2026/from-bench-to-preclinical-evaluation-ll-37-derived-peptides-for-combating-orthopedic-infections 0.8 https://infectiouscongress.com/program/scientific-program/2026/single-step-immunoblot-tests-with-recombinant-protein-antigens-for-detecting-igg-and-igm-antibodies-in-lyme-disease 0.8 https://infectiouscongress.com/program/scientific-program/2026/mathematical-modeling-of-covid-19-dynamics-in-a-west-african-context 0.8 https://infectiouscongress.com/program/scientific-program/2026/tlr9-dependent-modulation-of-adipocyte-differentiation-by-brucella-abortus-dna-induces-an-inflammatory-response 0.8 https://infectiouscongress.com/program/scientific-program/2026/pneumocystis-pneumonia-in-immunocompetent-children 0.8 https://infectiouscongress.com/program/scientific-program/2026/regulation-of-dikaryotic-arbuscular-mycorrhizal-fungal-infection-in-vigna-angularis-vigna-radiata-and-allium-tuberosum-by-glomus-mosseae 0.8 https://infectiouscongress.com/program/scientific-program/2026/regulation-of-dikaryotic-arbuscular-mycorrhizal-fungal-infection-in-vigna-angularis-vigna-radiata-allium-tuberosum-by-glomus-mosseae 0.8 https://infectiouscongress.com/program/scientific-program/2026/genomic-diversity-of-orthohantavirus-andesense-andv-impact-of-non-synonymous-snvs-on-gene-expression-and-immune-system-evasion 0.8 https://infectiouscongress.com/program/scientific-program/2026/efficacy-and-safety-of-biologic-therapies-for-inflammatory-bowel-disease-a-systematic-review-from-a-nursing-perspective 0.8 https://infectiouscongress.com/program/scientific-program/2026/e2-ubiquitin-conjugating-enzymes-regulates-dengue-virus-2-replication-in-aedes-albopictus 0.8 https://infectiouscongress.com/program/scientific-program/2026/emerging-burden-of-non-tuberculous-mycobacteria-in-mgit-based-tuberculosis-cultures-insights-from-south-india 0.8 https://infectiouscongress.com/program/scientific-program/2026/simultaneous-inhibition-of-terminal-oxidases-eradicates-heterogenous-population-of-mycobacterium-tuberculosis 0.8 https://infectiouscongress.com/program/scientific-program/2026/crispr-based-point-of-care-diagnostics-for-real-time-surveillance-of-fmdv-and-lsdv-under-the-one-health-framework 0.8 https://infectiouscongress.com/program/scientific-program/2026/creutzfeldt-jakob-disease-in-the-philippines-diagnostic-challenges-clinical-features-and-insights-from-the-first-multicenter-registry-and-descriptive-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2026/neuroschistosomiasis-in-an-adolescent-presenting-with-seizure-and-headache-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/pcr-guided-diagnosis-and-intrathecal-salvage-therapy-for-capnocytophaga-brain-abscess-with-polymicrobial-anaerobic-ventriculitis-in-an-immunocompetent-host 0.8 https://infectiouscongress.com/program/scientific-program/2026/rare-cause-of-septic-arthritis-knee-infection-by-streptococcus-sanguinis-post-intra-articular-injection 0.8 https://infectiouscongress.com/program/scientific-program/2026/severe-pharyngo-cervical-infection-and-persistent-oropharyngeal-cervical-fistula-following-needle-aspiration-in-a-previously-irradiated-clival-chordoma-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-rare-co-occurrence-of-streptococcus-pyogenes-meningitis-and-anti-n-methyl-d-aspartate-receptor-encephalitis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/legionella-scientific-considerations-on-this-pathogen-threatening-the-civilized-world-why-not-albania 0.8 https://infectiouscongress.com/program/scientific-program/2026/evaluating-the-effectiveness-of-antimicrobial-stewardship-on-escherichia-coli-resistance-in-patients-with-urinary-tract-infection-a-systematic-review-and-meta-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2026/diastolic-shock-index-as-an-early-failure-to-normalize-marker-of-persistent-vasodilatory-physiology-in-infection-related-critical-illness 0.8 https://infectiouscongress.com/program/scientific-program/2026/challenges-in-biofilm-quantification-and-the-emerging-role-of-hyperspectral-imaging 0.8 https://infectiouscongress.com/program/scientific-program/2026/intravenous-drug-users-and-spondylodiscitis-as-an-associated-infection-a-serious-public-health-problem-at-the-global-level-including-in-albania 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-comparison-of-current-treatments-for-clostridioides-difficile-infection-in-adults-and-children 0.8 https://infectiouscongress.com/program/scientific-program/2026/archaeological-and-genetic-evidence-of-earliest-records-of-plague-endemic-5-100-5-600-years-bp-and-its-especial-relevance-to-zoonotic-pathogen-ecology-human-resilience-public-awareness-and-health-policy 0.8 https://infectiouscongress.com/program/scientific-program/2026/optimizing-oral-cholera-vaccine-allocation-pre-emptive-vs-reactive-strategies-under-uncertainty 0.8 https://infectiouscongress.com/program/scientific-program/2026/structure-conserved-sequence-divergent-rna-motifs-in-nipah-virus-reveal-mutation-resistant-therapeutic-targets-missed-by-protein-centric-design 0.8 https://infectiouscongress.com/program/scientific-program/2026/immunogenicity-and-safety-of-inactivated-sars-cov-2-vaccine-coronavac-using-a-two-dose-primary-protocol-in-children-and-adolescents-immunita-002-brazil-a-phase-iv-one-year-follow-up 0.8 https://infectiouscongress.com/program/scientific-program/2026/discovery-of-reintroduction-source-and-amplification-vectors-of-highly-pathogenic-avian-influenza 0.8 https://infectiouscongress.com/program/scientific-program/2026/structural-studies-of-the-hemagglutinin-membrane-interaction 0.8 https://infectiouscongress.com/program/scientific-program/2026/severe-legionella-pneumonia-case-series-at-an-urban-academic-medical-center 0.8 https://infectiouscongress.com/program/scientific-program/2026/severe-legionella-pneumonia-case-series-at-a-urban-academic-medical-center 0.8 https://infectiouscongress.com/program/scientific-program/2026/sep-1-compliance-metrics-following-the-sepsis-tool-implementation-project-utilizing-the-epic-2-0-sepsis-prediction-model 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-cog-in-the-weil 0.8 https://infectiouscongress.com/program/scientific-program/2026/sporotrichosis-case-report-and-review-of-sporotrichosis-clinical-presentation-diagnosis-antifungal-susceptibility-and-united-states-epidemiology 0.8 https://infectiouscongress.com/program/scientific-program/2026/sepsis-induced-gastrointestinal-dysfunction-an-atypical-initial-presentation-of-infective-endocarditis 0.8 https://infectiouscongress.com/program/scientific-program/2026/co-infection-of-pneumocystis-jirovecii-and-mycobacterium-tuberculosis-in-a-patient-with-granulomatosis-with-polyangiitis-a-diagnostic-and-therapeutic-challenge 0.8 https://infectiouscongress.com/program/scientific-program/2026/epidemiological-profile-of-gestational-toxoplasmosis-in-brazil-from-2019-to-2024 0.8 https://infectiouscongress.com/program/scientific-program/2026/virulence-factors-and-genetic-diversity-of-trypanosoma-cruzi-implications-for-pathogenesis-mechanisms 0.8 https://infectiouscongress.com/program/scientific-program/2026/atypical-neurological-and-ophthalmic-debut-of-aids-with-dual-opportunistic-infection-cryptococcal-meningitis-and-cytomegalovirus-retinitis 0.8 https://infectiouscongress.com/program/scientific-program/2026/risk-factors-of-the-early-onset-of-catheter-related-bloodstream-infection-among-hemodialysis-patients-admitted-at-a-tertiary-hospital-a-5-year-retrospective-analysis-2018-2022 0.8 https://infectiouscongress.com/program/scientific-program/2026/catastrophic-unmasking-fatal-tuberculosis-associated-iris-presenting-as-acute-liver-failure-in-pregnancy 0.8 https://infectiouscongress.com/program/scientific-program/2026/prevalence-and-microbiologic-profile-of-catheter-related-bloodstream-infections-in-chronic-kidney-disease-patients-in-baguio-general-hospital-and-medical-center 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-case-of-neurosyphilis-presenting-as-dyschromatopsia-in-an-immunocompetent-filipino-adult 0.8 https://infectiouscongress.com/program/scientific-program/2026/clinical-profile-of-candidemia-in-children-a-10-year-experience-from-a-tertiary-care-centre-in-india 0.8 https://infectiouscongress.com/program/scientific-program/2026/vegetable-associated-escherichia-coli-st446-carrying-blactx-m-1-and-mcr-1-raises-concerns-regarding-difficult-to-treat-foodborne-infections 0.8 https://infectiouscongress.com/program/scientific-program/2026/modeling-climate-effects-on-mosquito-abundance-in-an-arid-environment-link-to-vector-borne-disease-risk 0.8 https://infectiouscongress.com/program/scientific-program/2026/early-prosthetic-joint-infection-of-the-knee-due-to-clostridiodes-difficile-following-episode-of-colitis 0.8 https://infectiouscongress.com/program/scientific-program/2026/bioterrorism-through-the-ages-historical-perspective-emerging-threats-and-medical-countermeasures 0.8 https://infectiouscongress.com/program/scientific-program/2026/measles-vaccination-coverage-indicators-in-2023-and-advance-towards-measles-elimination-and-eradication-by-2030 0.8 https://infectiouscongress.com/program/scientific-program/2026/physician-awareness-and-health-system-strategies-for-improving-influenza-vaccination-uptake 0.8 https://infectiouscongress.com/program/scientific-program/2026/genetic-strains-of-mycobacterium-tuberculosis-among-indigenous-populations-a-molecular-epidemiology-analysis-of-first-nation-communities-in-northern-saskatchewan 0.8 https://infectiouscongress.com/program/scientific-program/2026/the-impact-of-expanded-adolescent-vaccination-against-omicron-waves-depends-on-the-epidemic-status-a-mathematical-modelling-study 0.8 https://infectiouscongress.com/program/scientific-program/2026/targeting-vitamins-b1-b3-and-b5-metabolism-reduces-streptococcus-pneumoniae-virulence-in-a-murine-influenza-co-infection-model 0.8 https://infectiouscongress.com/program/scientific-program/2026/neurotoxoplasmosis-with-spinal-cord-involvement-a-rare-case 0.8 https://infectiouscongress.com/program/scientific-program/2026/angioinvasive-mucormycosis-following-sars-cov-2-infection-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/gaps-in-clinical-and-ethical-guidance-during-health-crises-lessons-from-the-covid-19-pandemic-in-m-xico 0.8 https://infectiouscongress.com/program/scientific-program/2026/antibiotics-dispensing-in-tuberculosis-patients-using-standardized-patient-approach-results-from-a-cross-sectional-study-from-community-pharmacies-in-punjab-pakistan 0.8 https://infectiouscongress.com/program/scientific-program/2026/using-unannounced-standardized-patients-to-assess-quality-of-tuberculosis-care-and-antibiotic-prescribing-a-cross-sectional-study-from-a-low-middle-income-country-pakistan 0.8 https://infectiouscongress.com/program/scientific-program/2026/breaking-the-chain-how-rapid-investigation-and-product-recall-ended-a-pseudomonas-aeruginosa-bloodstream-infection-outbreak-in-a-cardiac-tertiary-care-center 0.8 https://infectiouscongress.com/program/scientific-program/2026/novel-antimalarial-compound-2741-19-synergistically-kills-p-falciparum-in-vitro-with-artemisinin-combination-therapy-partner-drug-piperaquine 0.8 https://infectiouscongress.com/program/scientific-program/2026/decade-long-surveillance-of-rotavirus-genotype-diversity-pre-and-post-vaccine-introduction-among-under-five-children-with-diarrhoea-at-the-university-of-ilorin-teaching-hospital-nigeria-2013-2023 0.8 https://infectiouscongress.com/program/scientific-program/2026/cell-type-specific-immunometabolic-dichotomy-distinguishes-mis-c-from-kawasaki-disease 0.8 https://infectiouscongress.com/program/scientific-program/2026/association-of-menopause-and-long-covid-symptoms-on-vascular-outcomes-amlov-study 0.8 https://infectiouscongress.com/program/scientific-program/2026/optimising-hepatitis-b-antiviral-prescribing-in-a-rural-nhs-population-a-quality-improvement-study-demonstrating-50k-annual-trust-savings 0.8 https://infectiouscongress.com/program/scientific-program/2026/strengthening-immunization-systems-in-a-decentralized-health-system-availability-and-readiness-of-primary-healthcare-services-in-the-federation-of-bosnia-and-herzegovina 0.8 https://infectiouscongress.com/program/scientific-program/2026/bacteremia-from-e-cloacae-e-faecalis-c-tropicalis-cardiac-device-related-endocarditis-and-septic-arthritis-from-c-tropicalis 0.8 https://infectiouscongress.com/program/scientific-program/2026/bacterial-resistance-patterns-and-associated-factors-in-pediatric-urinary-tract-infections-a-susceptibility-profile-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-signal-in-early-canadian-viral-surveillance-efforts-for-sars-cov-2 0.8 https://infectiouscongress.com/program/scientific-program/2026/assessment-of-vaccination-with-ama1-of-plasmodium-knowlesi-expressed-in-pichia-pastoris-against-chimeric-rodent-malaria-parasite 0.8 https://infectiouscongress.com/program/scientific-program/2026/pioneering-d-mavs-designable-multi-antivirals-that-transform-how-antivirals-are-created-developed-and-used 0.8 https://infectiouscongress.com/program/scientific-program/2026/hypothesis-linking-the-major-predisposing-factors-for-multiple-sclerosis-including-epstein-barr-virus-infection-to-its-etiology 0.8 https://infectiouscongress.com/program/scientific-program/2026/when-pneumococcal-meningoencephalitis-masquerades-as-stroke-recognizing-immune-turning-point 0.8 https://infectiouscongress.com/program/scientific-program/2026/lenacapavir-for-hiv-treatment-and-pre-exposure-prophylaxis-evaluating-efficacy-and-safety-a-systematic-review-and-meta-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2026/when-pneumococcal-meningoencephalitis-masquerades-as-stroke-recognizing-the-immune-turning-point 0.8 https://infectiouscongress.com/program/scientific-program/2026/epstein-barr-virus-associated-autonomic-neuropathy-presenting-as-isolated-severe-orthostatic-hypotension 0.8 https://infectiouscongress.com/program/scientific-program/2026/protective-efficacy-of-a-novel-trivalent-inactivated-salmonella-vaccine-against-salmonella-infantis-in-hy-line-brown-chickens 0.8 https://infectiouscongress.com/program/scientific-program/2026/dengue-fever-uncovers-a-late-diagnosis-of-sickle-cell-disease-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/unexpected-pulmonary-cryptococcosis-in-an-immunocompetent-individual-case-report-and-clinical-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2026/outbreak-of-pulmonary-histoplasmosis-in-cienfuegos-province 0.8 https://infectiouscongress.com/program/scientific-program/2026/infected-pseudoaneurysm-from-septic-embolism-of-the-left-common-iliac-artery-in-a-seventy-five-year-old-man 0.8 https://infectiouscongress.com/program/scientific-program/2026/surviving-a-rare-multifocal-musculoskeletal-infection-with-concomitant-septic-myocarditis-from-s-dysgalactiae-bacteremia-in-a-50-year-old-male-filipino-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/risk-factors-of-acinetobacter-baumannii-infection-among-patients-in-the-intensive-care-unit-of-a-tertiary-hospital-in-cebu-city 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-double-mutant-of-mycobacterium-tuberculosis-targeting-membrane-transporters-ctpf-and-mmpl7-as-a-promising-live-attenuated-vaccine-candidate 0.8 https://infectiouscongress.com/program/scientific-program/2026/risk-of-tuberculosis-in-patients-with-autoimmune-diseases-treated-with-biologic-therapies-a-retrospective-cohort-study-in-colombia 0.8 https://infectiouscongress.com/program/scientific-program/2026/equities-and-inequities-inherent-in-wastewater-surveillance-systems-for-public-health 0.8 https://infectiouscongress.com/program/scientific-program/2026/multicomponent-school-based-strategies-to-improve-influenza-vaccination-uptake-in-low-resource-china-interim-analysis-of-a-five-arm-cluster-randomized-trial 0.8 https://infectiouscongress.com/program/scientific-program/2026/the-risk-of-hepatitis-b-reactivation-during-immunosuppressive-therapy-in-b-cell-cancers-the-role-of-antiviral-prevention 0.8 https://infectiouscongress.com/program/scientific-program/2026/nocardiosis-an-elusive-insidious-infection-a-case-report-of-disseminated-nocardiosis-with-concurrent-bloodstream-infection 0.8 https://infectiouscongress.com/program/scientific-program/2026/temporal-shifts-in-antibacterial-susceptibility-during-the-phased-expansion-of-a-tertiary-care-centre 0.8 https://infectiouscongress.com/program/scientific-program/2026/card-linkml-connecting-the-dots-to-develop-frameworks-for-multicomponent-antibiotic-resistance 0.8 https://infectiouscongress.com/program/scientific-program/2026/the-risk-of-hepatitis-b-reactivation-during-immunosuppressive-therapy-in-b-cells-cancers-the-role-of-antiviral-prevention 0.8 https://infectiouscongress.com/program/scientific-program/2026/quadruple-valve-endocarditis-due-to-candida-parapsilosis-a-previously-unreported-presentation 0.8 https://infectiouscongress.com/program/scientific-program/2026/epidemiological-profile-diagnosis-and-treatment-of-pleural-empyema-in-pediatric-population-treated-at-a-tertiary-hospital-in-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2026/epidemiological-profile-diagnosis-and-treatment-of-pleural-empyema-in-adult-population-treated-at-a-tertiary-hospital-in-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2026/personalized-and-precision-medicine-ppm-as-a-unique-healthcare-model-to-se-cure-the-human-healthcare-wellness-and-biosafety-through-the-view-of-public-health-network-driven-healthcare-services-and-lifestyle-management 0.8 https://infectiouscongress.com/program/scientific-program/2026/robust-protection-against-monkeypox-virus-mediated-by-a-novel-cell-line-derived-mva-vaccine-tg-mva 0.8 https://infectiouscongress.com/program/scientific-program/2026/pathogen-derived-noncanonical-epitopes-are-they-valuable-targets-for-novel-vaccinations-and-shall-we-be-concerned-about-autoimmune-responses 0.8 https://infectiouscongress.com/program/scientific-program/2026/severe-influenza-and-other-related-respiratory-infection-cases-during-omicron-era-in-japan 0.8 https://infectiouscongress.com/program/scientific-program/2026/mechanisms-of-mesenchymal-stem-cells-and-msc-exo-in-therapy-of-infection-related-ards 0.8 https://infectiouscongress.com/program/scientific-program/2026/new-paradigms-of-irf-biology-in-virus-infection 0.8 https://infectiouscongress.com/program/scientific-program/2026/molecular-and-cellular-communication-between-the-host-and-path-in-streptococcus-pyogenes-infections 0.8 https://infectiouscongress.com/program/scientific-program/2026/sexually-transmitted-and-blood-borne-infections-among-people-living-with-hiv-in-high-income-countries-a-systematic-review-and-meta-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2026/the-transformation-of-personalized-and-precision-medicine-ppm-model-towards-infectious-diseases-monitoring-management-from-mass-vaccination-to-person-alized-vaccinomics 0.8 https://infectiouscongress.com/program/scientific-program/2026/illuminating-new-frontiers-exploring-the-photosensitizing-potential-of-passiflora-species-in-combatting-methicillin-resistant-staphylococcus-aureus-mrsa-and-their-infection-in-senescent-mice 0.8 https://infectiouscongress.com/program/scientific-program/2026/when-acute-ebv-mimics-hiv-a-case-of-false-positive-p24-antigen-and-low-level-hiv-antibody-reactivity 0.8 https://infectiouscongress.com/program/scientific-program/2026/solitary-neurocysticercosis-mimicking-a-parietal-brain-tumour-in-a-young-woman-a-diagnostic-challenge 0.8 https://infectiouscongress.com/program/scientific-program/2026/collaborative-innovation-in-infection-control-redesigning-clinical-hand-basin-use-through-circles-of-influence-in-a-multi-site-hospital-initiative 0.8 https://infectiouscongress.com/program/scientific-program/2026/strengthening-four-communities-of-practice-of-the-one-health-knowledge-nexus-a-community-driven-platform-for-operationalizing-one-health 0.8 https://infectiouscongress.com/program/scientific-program/2026/comparative-analysis-of-time-series-models-for-predicting-dengue-outbreaks-in-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-new-universal-fever-definition-and-the-unscientific-nature-of-the-conservative-fever-definition 0.8 https://infectiouscongress.com/program/scientific-program/2026/non-albicans-candidemia-in-intensive-care-units-of-a-tertiary-care-hospital-and-the-antifungal-susceptibility-pattern-of-the-isolates-along-with-biofilm-formation 0.8 https://infectiouscongress.com/program/scientific-program/2026/the-hidden-burden-of-human-parvovirus-b19-infection-among-patients-with-suspected-dengue-fever 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-rare-case-of-meningitis-and-septicemia-due-to-streptococcus-acidominimus 0.8 https://infectiouscongress.com/program/scientific-program/2026/association-between-cardiometabolic-risk-factors-and-covid-19-severity-in-patients-of-a-rural-tertiary-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2026/diagnostic-concordance-between-multiplex-pcr-and-conventional-culture-for-pathogen-identification-and-antimicrobial-resistance-detection-implications-for-clinical-decision-making-in-infectious-disease-management 0.8 https://infectiouscongress.com/program/scientific-program/2026/electroacupuncture-based-medicament-testing-as-a-tool-for-exploring-viral-migration-patterns-in-long-covid 0.8 https://infectiouscongress.com/program/scientific-program/2026/electroacupuncture-based-medicament-testing-as-an-investigational-diagnostic-and-functional-assessment-tool-in-long-covid 0.8 https://infectiouscongress.com/program/scientific-program/2026/herpes-zoster-ophthalmicus-following-platelet-rich-plasma-therapy-for-androgenetic-alopecia-a-probable-adverse-reaction 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-case-of-possible-cmv-pneumonia-after-liver-transplantation-and-management-of-cmv-infection 0.8 https://infectiouscongress.com/program/scientific-program/2026/circulating-levels-of-il-17a-in-group-b-streptococcus-colonized-pregnant-women-a-promising-indicator-of-the-risk-of-neonatal-complications 0.8 https://infectiouscongress.com/program/scientific-program/2026/validity-of-the-pediatric-age-adjusted-shock-index-in-the-early-assessment-of-shock-among-patients-with-sepsis-a-five-year-review 0.8 https://infectiouscongress.com/program/scientific-program/2026/genomic-surveillance-guided-adaptive-allocation-significantly-reduces-projected-malaria-incidence-under-artemisinin-resistance 0.8 https://infectiouscongress.com/program/scientific-program/2026/role-of-serial-serum-procalcitonin-levels-in-predicting-severity-and-outcome-in-sepsis-and-its-utility-in-antibiotic-stewardship-at-a-tertiary-care-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2026/unilateral-ptosis-proptosis-and-limb-weakness-unusual-signs-of-a-rare-complication-lemierre-s-syndrome-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/ultrasound-diagnosis-of-hepatic-echinococcosis-using-a-deep-convolutional-neural-network-model-in-china-a-large-scale-multicentre-diagnostic-accuracy-study 0.8 https://infectiouscongress.com/program/scientific-program/2026/clinical-outcomes-and-choice-of-antibiotics-in-ampc-beta-lactamase-hyperproducing-enterobacterales-bacteremia-a-single-centre-study 0.8 https://infectiouscongress.com/program/scientific-program/2026/utility-of-infection-disease-compartmental-models-to-test-the-competing-hypotheses-of-pathogen-evolution-and-human-intervention 0.8 https://infectiouscongress.com/program/scientific-program/2026/from-gut-dysbiosis-to-lung-vulnerability-influenza-risk-in-diabetes 0.8 https://infectiouscongress.com/program/scientific-program/2026/from-oral-flora-to-embolic-disease-a-case-of-streptococcus-salivarius-endocarditis-presenting-with-splenic-infarction-in-a-young-patient 0.8 https://infectiouscongress.com/program/scientific-program/2026/standardization-of-parasitic-and-molecular-techniques-for-the-detection-and-characterization-of-toxocara-spp-from-feces-and-soil 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-case-of-silent-chronic-hepatitis-b-following-uncontrolled-treatment-discontinuation-can-antiviral-treatment-be-discontinued-in-chronic-hepatitis-b 0.8 https://infectiouscongress.com/program/scientific-program/2026/solitary-neurocysticercosis-mimicking-a-parietal-brain-tumour-in-young-woman-a-diagnostic-challenge 0.8 https://infectiouscongress.com/program/scientific-program/2026/empirical-antibiotic-coverage-for-bacteraemia-a-seasonal-audit-across-hampshire-hospitals-nhs-foundation-trust 0.8 https://infectiouscongress.com/program/scientific-program/2026/coagulopathy-a-hidden-enemy-in-persistent-organ-dysfunction-in-post-septic-rats 0.8 https://infectiouscongress.com/program/scientific-program/2026/coexisting-rifampicin-resistant-peritoneal-tuberculosis-and-ventriculoperitoneal-shunt-related-csf-pseudocyst-presenting-as-a-pelvic-mass-a-complex-diagnostic-intersection 0.8 https://infectiouscongress.com/program/scientific-program/2026/opportunistic-central-nervous-system-infections-and-transplant-rejection-in-solid-organ-transplant-recipients-a-scoping-review 0.8 https://infectiouscongress.com/program/scientific-program/2026/dual-tick-borne-infection-severe-babesiosis-and-lyme-coinfection-complicated-by-multisystem-organ-dysfunction 0.8 https://infectiouscongress.com/program/scientific-program/2026/atypical-presentation-of-disseminated-herpes-zoster-in-an-immunocompetent-adult 0.8 https://infectiouscongress.com/program/scientific-program/2026/endocarditis-contemporary-clinical-microbiological-and-therapeutic-insights-with-emphasis-on-prognostic-precision 0.8 https://infectiouscongress.com/program/scientific-program/2026/recurrent-suppurative-hidradenitis-of-the-breast-in-a-59-year-old-woman-a-clinically-deceptive-entity-mimicking-malignancy-diagnostic-pitfalls-and-surgical-insights 0.8 https://infectiouscongress.com/program/scientific-program/2026/anti-proliferative-and-metabolic-activity-of-the-compounds-caffeic-acid-and-oregano-essential-oil-in-human-trophoblast-cells-infected-with-the-rh-strain-of-toxoplasma-gondii 0.8 https://infectiouscongress.com/program/scientific-program/2026/acquired-immunodeficiency-syndrome-with-multiple-opportunistic-coinfections-tuberculosis-cytomegalovirus-pneumocystis-pneumonia-and-malaria-report-of-a-rare-and-challenging-case 0.8 https://infectiouscongress.com/program/scientific-program/2026/takotsubo-syndrome-as-a-rare-complication-in-a-young-patient-with-pulmonary-tuberculosis-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/rifampicin-resistant-meningeal-tuberculosis-in-an-immunocompromised-patient-with-hiv-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/community-associated-invasive-infection-by-methicillin-resistant-staphylococcus-aureus-in-an-immunocompetent-adolescent-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/severe-acute-respiratory-distress-syndrome-secondary-to-viral-pneumonia-caused-by-varicella-zoster-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/fulminant-hepatic-failure-associated-with-hepatitis-a-virus-in-a-previously-healthy-patient-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/rare-complication-of-dengue-fever-severe-acute-liver-failure-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/legionella-pneumophila-pneumonia-an-underdiagnosed-disease-but-with-a-high-impact 0.8 https://infectiouscongress.com/program/scientific-program/2026/reporting-a-case-of-ankylosing-spondylitis-a-condition-to-be-differentiated-from-infectious-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2026/clinico-bacteriological-characteristics-and-clinical-outcomes-in-acute-exacerbation-of-copd-a-2-year-retrospective-review-of-patient-data 0.8 https://infectiouscongress.com/program/scientific-program/2026/vancomycin-levels-in-csf-versus-brain-ecf-which-compartment-reflects-the-target-site-in-postoperative-meningoencephalitis 0.8 https://infectiouscongress.com/program/scientific-program/2026/peritonitis-complicating-body-packing-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2026/prognostic-role-of-fever-in-severe-brain-trauma 0.8 https://infectiouscongress.com/program/scientific-program/2026/does-kp-sepsis-calculator-provide-more-reliable-accurate-and-efficient-screening-and-treatment-for-early-onset-neonatal-sepsis-as-compared-to-nice-guidelines-kch-experience 0.8 https://infectiouscongress.com/program/scientific-program/2026/knowledge-attitude-and-practices-pertaining-to-latent-tuberculosis-among-household-contacts-of-patients-diagnosed-with-bacteriologically-confirmed-pulmonary-tuberculosis-in-the-seven-districts-of-iloilo-city 0.8 https://infectiouscongress.com/program/scientific-program/2026/impact-of-the-covid-19-pandemic-on-tuberculosis-diagnosis-and-outcomes-among-hiv-coinfected-patients 0.8 https://infectiouscongress.com/program/scientific-program/2026/mucormycosis-in-patients-with-diabetes-mellitus-new-data-after-the-covid-19-pandemic 0.8 https://infectiouscongress.com/program/scientific-program/2026/invasive-fungal-infections-caused-by-non-candida-yeast-like-fungi-result-of-a-prospective-study 0.8 https://infectiouscongress.com/program/scientific-program/2026/severe-post-influenza-complications-leading-to-multiligamentous-limb-amputation-in-a-pediatric-patient 0.8 https://infectiouscongress.com/program/scientific-program/2026/breaking-the-mupirocin-paradox-light-activated-nasal-decolonization-achieves-66-ssi-reduction-and-sustained-cost-savings-without-resistance-signals-in-spine-surgery-over-8-years 0.8 https://infectiouscongress.com/program/scientific-program/2026/the-double-whammy-of-cardiac-ssi-under-reporting-correcting-incidence-and-inflation-to-unlock-capacity-and-eradicate-amr-debt 0.8 https://infectiouscongress.com/program/scientific-program/2026/critical-risk-factors-for-covid-19-associated-pulmonary-aspergillosis-identified-in-hospitalised-patients 0.8 https://infectiouscongress.com/program/scientific-program/2026/determinants-of-symptoms-experienced-following-covid-19-vaccinations-among-health-workers-at-a-tertiary-hospital-in-southwestern-nigeria 0.8 https://infectiouscongress.com/program/scientific-program/2026/a-case-report-of-clostridium-perfringens-sepsis-and-haemolytic-anaemia-in-endometrial-cancer 0.8 https://infectiouscongress.com/program/scientific-program/2026/institutional-gaps-and-healthcare-inequalities-blood-borne-virus-healthcare-from-prison-to-the-community 0.8 https://infectiouscongress.com/program/scientific-program/2026/decision-making-regarding-maternal-vaccination-a-multifactorial-phenomenon-from-the-perspective-of-pregnant-women-and-healthcare-staff 0.8 https://infectiouscongress.com/program/scientific-program/2025/2000-years-of-pandemics-past-present-and-future 0.8 https://infectiouscongress.com/program/scientific-program/2025/role-of-mast-cells-in-infection-and-inflammation 0.8 https://infectiouscongress.com/program/scientific-program/2025/tubercular-disease-in-children-optimizing-treatment-strategies-through-disease-insights 0.8 https://infectiouscongress.com/program/scientific-program/2025/rickettsial-disease-serodiagnosis-current-trends 0.8 https://infectiouscongress.com/program/scientific-program/2025/cognitive-behavioral-sequelae-of-non-severe-malaria-and-potential-strategies-for-its-mitigation 0.8 https://infectiouscongress.com/program/scientific-program/2025/antibiotic-profile-in-a-second-level-hospital-in-tepic-nayarit-mexico-2023 0.8 https://infectiouscongress.com/program/scientific-program/2025/effect-of-glutathione-on-antibiotic-susceptibility-and-resistance-in-bacteria 0.8 https://infectiouscongress.com/program/scientific-program/2025/fawcells-the-universal-alternative-for-antibiotics 0.8 https://infectiouscongress.com/program/scientific-program/2025/characterization-of-virologic-immunologic-failure-and-discordance-among-new-hiv-infected-adults-in-the-upper-southern-region-of-thailand 0.8 https://infectiouscongress.com/program/scientific-program/2025/disseminated-fusariosis-management-conundrum-a-fatal-case-in-an-immunocompromised-patient 0.8 https://infectiouscongress.com/program/scientific-program/2025/first-application-of-cut-tag-in-bacteria-reveals-unconventional-g-quadruplex-landscape-in-mycobacterium-tuberculosis-a-novel-defense-mechanism-against-oxidative-stress 0.8 https://infectiouscongress.com/program/scientific-program/2025/novel-antibiotic-adjuvant-exerts-potent-antimicrobial-activity-against-mrsa-and-synergistically-restores-colistin-activity-in-mdro 0.8 https://infectiouscongress.com/program/scientific-program/2025/universal-pcr-assays-to-detect-candida-fks-and-erg11-mutations 0.8 https://infectiouscongress.com/program/scientific-program/2025/crispr-cas-powered-pen-side-diagnostic-tests-for-the-early-detection-of-the-tick-borne-pathogens-theileria-parva-anaplasma-marginale-and-babesia-bigemina 0.8 https://infectiouscongress.com/program/scientific-program/2025/risk-of-visceral-leishmaniasis-resurgence-in-india-a-compartmental-modelling-study 0.8 https://infectiouscongress.com/program/scientific-program/2025/microbiological-activity-of-bovhyaluronidaze-azoximer-against-microbial-biofilms 0.8 https://infectiouscongress.com/program/scientific-program/2025/identification-of-airborne-fungus-in-residential-environments-that-contribute-to-allergic-bronchopulmonary-asthma-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2025/effect-of-an-immunomodulator-rs100-in-vaccinated-unvaccinated-and-challenged-with-mycoplasma-hyopneumoniae 0.8 https://infectiouscongress.com/program/scientific-program/2025/reversal-of-metabolic-reprogramming-as-a-therapeutic-strategy-in-early-sepsis 0.8 https://infectiouscongress.com/program/scientific-program/2025/enhancing-antibiotic-therapy-for-sstis-the-diagnostic-role-of-punch-biopsy 0.8 https://infectiouscongress.com/program/scientific-program/2025/mitigate-cross-contamination-hazards-by-sorting-samples-within-a-closed-cartridge 0.8 https://infectiouscongress.com/program/scientific-program/2025/antimicrobial-resistance-in-pathogens-isolated-from-raw-milk-and-fresh-goat-cheese 0.8 https://infectiouscongress.com/program/scientific-program/2025/illness-severity-in-patients-with-severe-fever-with-thrombocytopenia-syndrome-sfts-assessed-by-multiple-organ-dysfunction-score-mods-a-guide-for-physicians-in-monitoring-and-treatment-decisions 0.8 https://infectiouscongress.com/program/scientific-program/2025/cytokine-storm-control-in-severe-fever-with-thrombocytopenia-syndrome-tocilizumab-s-potential-role-in-reducing-il-6-and-mortality 0.8 https://infectiouscongress.com/program/scientific-program/2025/association-between-obesity-and-dengue-severity-in-a-tertiary-pediatric-hospital-in-the-philippines 0.8 https://infectiouscongress.com/program/scientific-program/2025/invasive-fungal-sinusitis-correlation-of-the-radiological-and-intraoperative-findings 0.8 https://infectiouscongress.com/program/scientific-program/2025/study-on-surface-disinfection-of-254-nm-pulsed-ultraviolet-laser 0.8 https://infectiouscongress.com/program/scientific-program/2025/study-on-surface-disinfection-of-254-nm-pulsed-ultraviolet-laser 0.8 https://infectiouscongress.com/program/scientific-program/2025/use-of-antifungal-agents-in-non-neutropenic-critically-ill-patients-to-decrease-invasive-fungal-infections-versus-placebo-a-systematic-review-and-meta-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2025/monitoring-the-characteristics-of-a-h1n1-influenza-viruses-circulating-in-post-2009-pandemic-flu-seasons-in-romania 0.8 https://infectiouscongress.com/program/scientific-program/2025/anti-ifn-autoantibody-syndrome-presenting-with-disseminated-ntm-infections-a-case-series-and-therapeutic-implications-and-review-of-literature 0.8 https://infectiouscongress.com/program/scientific-program/2025/global-environmental-changes-and-mosquito-borne-diseases-in-coastal-areas 0.8 https://infectiouscongress.com/program/scientific-program/2025/ethanol-inhalation-for-respiratory-infections-due-to-enveloped-viruses 0.8 https://infectiouscongress.com/program/scientific-program/2025/current-topics-of-adult-covid-19-influenza-and-rs-virus-patients-in-japan 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-impact-of-global-antibiotic-resistance-on-the-healthcare-system-public-health-environment-and-society 0.8 https://infectiouscongress.com/program/scientific-program/2025/advancing-serodiagnosis-of-tick-borne-borreliosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/loss-of-ballance 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-baseline-characteristics-of-patients-with-cognitive-symptoms-after-covid-19-infection-the-pasc24-study 0.8 https://infectiouscongress.com/program/scientific-program/2025/cryptococcal-meningitis-without-headache-a-case-report-highlighting-atypical-presentation 0.8 https://infectiouscongress.com/program/scientific-program/2025/tissue-invasive-disease-and-cytomegalovirus-cytomegalovirus-trigger-or-killer-two-cases-observed-in-an-internal-unit 0.8 https://infectiouscongress.com/program/scientific-program/2025/early-detection-of-hip-joint-infections-using-point-of-care-ultrasound-pocus-a-case-series 0.8 https://infectiouscongress.com/program/scientific-program/2025/beyond-the-clinical-eye-pocus-as-the-critical-differentiator-in-emergency-skin-and-soft-tissue-infection-management 0.8 https://infectiouscongress.com/program/scientific-program/2025/laparoscopic-heller-myotomy-with-anterior-fundoplication-in-an-elderly-male-patient-with-achalasia-and-coexisting-miliary-tuberculosis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2025/engaging-red-cross-inmate-volunteers-to-raise-awareness-and-advocate-for-disease-control-in-irish-prisons 0.8 https://infectiouscongress.com/program/scientific-program/2025/comparative-effectiveness-of-different-therapies-for-clostridioides-difficile-infection-in-adults-a-systematic-review-and-network-meta-analysis-of-randomized-controlled-trials 0.8 https://infectiouscongress.com/program/scientific-program/2025/risk-factors-of-mortality-and-development-of-a-scoring-system-for-predicting-mortality-among-patients-with-leptospirosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/risk-factors-of-mortality-and-development-of-a-scoring-system-for-predicting-mortality-among-patients-with-leptospirosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-platform-for-rapid-sensitive-detection-of-aerosolized-pathogens-in-exhaled-breath-and-ambient-indoor-air 0.8 https://infectiouscongress.com/program/scientific-program/2025/new-materials-to-provide-portable-rapid-diagnostic-point-of-care-detection-of-infectious-diseases-in-30-minutes-gram-negative-gram-positive-and-fungal-differentiation-via-enhanced-hyperselective-volume-phase-desolvation-nanomaterials 0.8 https://infectiouscongress.com/program/scientific-program/2025/informatics-approach-to-assess-mumps-vaccination 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-novel-device-for-preventing-ventilator-associated-pneumonia-in-the-intubated-patients 0.8 https://infectiouscongress.com/program/scientific-program/2025/prevalence-of-secondary-bacterial-pneumonia-co-infection-in-sars-cov-2-infected-patients-their-treatment-and-outcome-a-hospital-based-study 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-regulatory-mechanism-and-therapeutic-application-of-immune-checkpoint-in-alveolar-echinococcosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/disentangling-the-diagnostic-knot-uncovering-subcutaneous-panniculitis-like-t-cell-lymphoma-in-a-presumed-case-of-actinomycosis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2025/molecular-characterization-of-parvovirus-b19-in-patients-with-blood-dyscrasias 0.8 https://infectiouscongress.com/program/scientific-program/2025/liver-cancer-and-cirrhosis-as-a-complication-of-hcv-infection-a-case-study 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-underestimated-threat-a-review-of-ocular-leptospirosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/association-between-tuberculosis-and-guillain-barre-syndrome-a-systematic-review 0.8 https://infectiouscongress.com/program/scientific-program/2025/not-just-a-uti-a-rare-presentation-of-acute-urinary-retention-in-a-young-woman-due-to-genital-herpes 0.8 https://infectiouscongress.com/program/scientific-program/2025/covid-19-is-not-over-the-global-covid-community-council-advocates-for-change-to-support-medically-vulnerable-populations-post-pandemic 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-case-of-late-stage-hiv-diagnosis-despite-multiple-healthcare-encounters 0.8 https://infectiouscongress.com/program/scientific-program/2025/dengue-fever-the-silent-threat-risks-and-realities 0.8 https://infectiouscongress.com/program/scientific-program/2025/comparative-risk-of-acute-kidney-injury-with-piperacillin-tazobactam-plus-teicoplanin-versus-piperacillin-tazobactam-plus-vancomycin-a-systematic-review-and-meta-analysis-of-propensity-score-matched-studies 0.8 https://infectiouscongress.com/program/scientific-program/2025/lemierres-syndrome-following-streptococcus-anginosus-pharyngitis-an-unusual-case-of-a-forgotten-disease 0.8 https://infectiouscongress.com/program/scientific-program/2025/reactivation-of-human-herpesvirus-6-in-an-immunocompetent-patient-with-encephalitis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2025/epidemiological-survey-with-antigenic-fragments-of-hsp83-and-kpcr-in-population-at-risk-for-leishmaniasis 0.8 https://infectiouscongress.com/program/scientific-program/2025/systems-vaccinology 0.8 https://infectiouscongress.com/program/scientific-program/2025/post-covid-19-syndrome-in-honduras-systems-affected-and-its-association-with-severity-of-first-covid-19-episode 0.8 https://infectiouscongress.com/program/scientific-program/2025/preventing-early-onset-group-b-streptococcus-eogbs-a-narrative-review-of-bacteriological-screening-practices-in-the-uk 0.8 https://infectiouscongress.com/program/scientific-program/2025/preventing-early-onset-group-b-streptococcus-eogbs-a-narrative-review-of-bacteriological-screening-practices-in-the-united-kingdom 0.8 https://infectiouscongress.com/program/scientific-program/2025/preventing-early-onset-group-b-streptococcus-eogbs-a-narrative-review-of-bacteriological-screening-practice-in-the-united-kingdom 0.8 https://infectiouscongress.com/program/scientific-program/2025/preventing-early-onset-group-b-streptococcus-eogbs-a-narrative-review-of-bacteriological-screening-practice-in-the-uk 0.8 https://infectiouscongress.com/program/scientific-program/2025/preventing-early-onset-group-b-streptococcus-eogbs-narrative-review-of-bacteriological-screening-practices-in-the-uk 0.8 https://infectiouscongress.com/program/scientific-program/2025/hiv-1-subtypes-and-drug-resistance-in-newly-infected-children-through-vertical-transmission-in-peru-2020-2022 0.8 https://infectiouscongress.com/program/scientific-program/2025/an-unusual-presentation-of-creutzfeldt-jakob-disease-as-a-stroke-mimic 0.8 https://infectiouscongress.com/program/scientific-program/2025/improving-intravenous-vancomycin-monitoring-practices-a-multi-centre-quality-improvement-project-at-university-hospitals-birmingham 0.8 https://infectiouscongress.com/program/scientific-program/2025/virus-like-particle-inspired-particle-based-recombinant-schistosomiasis-vaccine-vipr 0.8 https://infectiouscongress.com/program/scientific-program/2025/cooling-tower-culprit-or-community-clue-a-modern-approach-to-legionella-surveillance 0.8 https://infectiouscongress.com/program/scientific-program/2025/revolutionary-incidents-exploiting-naturally-occurring-outbreaks-of-disease-for-military-gain 0.8 https://infectiouscongress.com/program/scientific-program/2025/proteome-dynamics-of-bacterial-pathogens-during-infection-new-drug-targets 0.8 https://infectiouscongress.com/program/scientific-program/2025/efficient-removal-of-antibiotics-from-water-using-a-highly-crosslinked-metal-alginate-system-a-novel-strategy-to-fight-against-antimicrobial-resistance 0.8 https://infectiouscongress.com/program/scientific-program/2025/marine-based-strategies-against-climate-driven-infectious-threats 0.8 https://infectiouscongress.com/program/scientific-program/2025/acute-pancreatitis-induced-by-ascaris-lumbricoides-in-the-context-of-acute-viral-hepatitis-a-literature-review-and-clinical-insights 0.8 https://infectiouscongress.com/program/scientific-program/2025/septic-thrombophlebitis-and-embolic-complications-in-an-18-year-old-a-rare-case-of-reverse-lemierre-s-syndrome 0.8 https://infectiouscongress.com/program/scientific-program/2025/isolated-internal-jugular-vein-thrombosis-as-the-initial-indicator-of-disseminated-tuberculosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/exploring-non-carbapenem-options-for-esbl-producing-enterobacteriaceae-bacteremia-in-emergency-room-focusing-on-piperacillin-tazobactam 0.8 https://infectiouscongress.com/program/scientific-program/2025/harnessing-bacteriophages-as-an-alternative-to-antibiotics-for-mastitis-prevention-in-goats-in-kenya 0.8 https://infectiouscongress.com/program/scientific-program/2025/surgical-site-infection-pre-and-post-covid-19-related-hygiene-protocols-in-gynaecological-oncology-is-there-a-difference-in-prevalence-and-severity-at-charlotte-maxeke-johannesburg-academic-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2025/genomic-epidemiology-informed-phage-therapy-tackling-acinetobacter-baumannii-infections-in-eastern-and-southern-europe 0.8 https://infectiouscongress.com/program/scientific-program/2025/establishment-of-a-comprehensive-assay-platform-for-supporting-the-discovery-of-agents-against-acute-and-latent-infections-of-herpes-simplex-viruses 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-impact-of-air-pollution-on-the-incidence-of-respiratory-infectious-diseases-in-children-in-kosova 0.8 https://infectiouscongress.com/program/scientific-program/2025/seroprevalence-of-measles-specific-igg-and-neutralizing-antibodies-in-clinically-confirmed-cases-from-the-ongoing-measles-outbreak-in-liberia 0.8 https://infectiouscongress.com/program/scientific-program/2025/antiviral-activity-of-different-molecules-obtained-from-invertebrates-against-coronavirus 0.8 https://infectiouscongress.com/program/scientific-program/2025/novel-nanotechnology-and-its-potential-applications 0.8 https://infectiouscongress.com/program/scientific-program/2025/covid-19-vaccination-strategies-in-the-post-pandemic-era 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-novel-device-for-preventing-ventilator-associated-pneumonia-in-intubated-patients 0.8 https://infectiouscongress.com/program/scientific-program/2025/controlling-pulmonary-inflammation-during-respiratory-virus-infection 0.8 https://infectiouscongress.com/program/scientific-program/2025/an-audit-into-the-time-taken-between-presentation-and-diagnosis-of-malaria-and-adherence-to-malaria-treatment-guidelines-at-southend-university-hospital-uk 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-multi-region-discrete-time-chain-binomial-model-for-infectious-disease-transmission 0.8 https://infectiouscongress.com/program/scientific-program/2025/comparison-of-the-ecological-footprint-of-disposable-versus-reusable-gowns-in-protecting-healthcare-providers-and-patients-against-the-transmission-of-sars-cov-2 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-time-driven-activity-based-costing-method-to-estimate-the-cost-of-personal-protective-equipment-use-in-the-emergency-department-during-the-covid-19-pandemic 0.8 https://infectiouscongress.com/program/scientific-program/2025/advancing-biosafety-in-microbial-sorting-a-novel-approach-to-containment-and-contamination-prevention 0.8 https://infectiouscongress.com/program/scientific-program/2025/application-of-minimally-invasive-surgical-techniques-in-pericardial-and-macrovascular-diseases-associated-with-infectious-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2025/development-of-amr-reference-reagents-for-amr-gene-detection-and-surveillance 0.8 https://infectiouscongress.com/program/scientific-program/2025/geostatistical-modelling-of-serological-multiplex-bead-assays-responses-a-case-study-from-malaysia 0.8 https://infectiouscongress.com/program/scientific-program/2025/one-health-animal-disaster-management-ohadm-decision-making-supporting-veterinarians-and-animals-in-disasters 0.8 https://infectiouscongress.com/program/scientific-program/2025/one-health-animal-disaster-management-ohadm-decision-making-supporting-veterinarians-and-animals-in-disaster 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-game-theoretic-approach-to-optimal-containment-policies-under-uncertainty-of-individuals-compliance 0.8 https://infectiouscongress.com/program/scientific-program/2025/zoonotic-potential-of-rotaviruses-detected-in-the-czech-pig-farms 0.8 https://infectiouscongress.com/program/scientific-program/2025/aetiology-risk-factors-and-early-outcomes-of-meningoencephalitis-in-east-africa-the-role-of-multiplex-pcr 0.8 https://infectiouscongress.com/program/scientific-program/2025/human-papillomavirus-types-by-cervical-dysplasia-hiv-status-and-the-diagnostic-value-of-cervical-screening-methods-in-eastern-kenya 0.8 https://infectiouscongress.com/program/scientific-program/2025/co-circulation-of-leishmania-phlebovirus-in-kala-azar-resurgence-area-in-china 0.8 https://infectiouscongress.com/program/scientific-program/2025/co-circulation-of-leishmania-phlebovirus-in-kala-azar-resurgence-area-in-china 0.8 https://infectiouscongress.com/program/scientific-program/2025/ultrastractural-and-molecular-characterization-of-sarcocystis-apecies-derived-from-macroscopic-sarcocysts-of-domestic-sheep-and-goats-in-soran-city-erbil-iraq 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-characterization-of-a-rhamnosilated-triterpenic-saponin-from-quillaja-saponaria-mol-reveals-novel-adjuvant-antibacterial-antiviral-and-antifungal-properties 0.8 https://infectiouscongress.com/program/scientific-program/2025/surgical-site-tb-a-hidden-killer 0.8 https://infectiouscongress.com/program/scientific-program/2025/multipronged-interventions-to-reduce-surgical-site-infections-a-multicenter-implementation-research-protocol 0.8 https://infectiouscongress.com/program/scientific-program/2025/prevalence-of-strongyloidiasis-and-its-risk-factors-in-pregnant-women-in-guilan-province-north-of-iran 0.8 https://infectiouscongress.com/program/scientific-program/2025/carbapenemase-resistance-genes-in-k-pneumoniae-from-clinical-samples 0.8 https://infectiouscongress.com/program/scientific-program/2025/post-covid-syndrome-among-covid-19-patients-at-national-hospital-kandy-sri-lanka 0.8 https://infectiouscongress.com/program/scientific-program/2025/misinformation-and-stigma-barriers-to-sti-prevention-among-albanian-youth 0.8 https://infectiouscongress.com/program/scientific-program/2025/immunization-against-medically-important-human-coronaviruses-of-public-health-concern 0.8 https://infectiouscongress.com/program/scientific-program/2025/clinical-trials-of-the-fully-automated-nucleic-acid-testing-system-labgenius-for-ct-ng-sti-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2025/clinical-trials-of-the-fully-automated-nucleic-acid-testing-system-labgenius-for-vre-infectious-disease 0.8 https://infectiouscongress.com/program/scientific-program/2025/rickettsiosis-presenting-as-viral-like-illness-a-case-report-highlighting-diagnostic-challenges-in-a-resource-limited-setting 0.8 https://infectiouscongress.com/program/scientific-program/2025/use-of-blood-culture-time-to-positivity-to-significantly-reduce-laboratory-workload 0.8 https://infectiouscongress.com/program/scientific-program/2025/associations-between-drb1-alleles-and-hiv-disease-progression-in-people-living-with-hiv-aids-plwha-receiving-antiretroviral-therapy-art 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-rising-trend-of-gram-negative-bacterial-infections-in-the-post-covid-era-and-military-conflict-in-ukraine 0.8 https://infectiouscongress.com/program/scientific-program/2025/cytomegalovirus-infection-in-the-early-phase-post-renal-transplantation-a-single-centre-experience 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-rare-case-of-spontaneous-splenic-rupture-in-a-young-patient-with-infectious-mononucleosis 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-retrospective-review-of-children-and-young-people-with-pertussis-positive-swabs-in-southern-health-and-social-care-trust-from-january-2024-to-august-2024 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-retrospective-review-of-children-and-young-people-with-pertussis-positive-swabs-in-the-southern-health-and-social-care-trust-from-january-2024-to-august-2024 0.8 https://infectiouscongress.com/program/scientific-program/2025/septic-thrombophlebitis-and-embolic-complications-in-an-18-year-old-a-rare-case-of-reverse-lemierre-s-syndrome 0.8 https://infectiouscongress.com/program/scientific-program/2025/diagnostic-performance-of-salivary-pcr-for-the-detection-of-congenital-cytomegalovirus-a-systematic-review-and-meta-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-rare-case-of-covid-19-complicated-with-severe-pneumonia-and-acute-arterial-thrombosis-of-a-lower-limb 0.8 https://infectiouscongress.com/program/scientific-program/2025/performance-of-gold-and-selenium-nanoparticles-in-lateral-flow-assays-for-hiv-p24-detection 0.8 https://infectiouscongress.com/program/scientific-program/2025/effectiveness-of-surveillance-tools-in-determining-drivers-of-dengue-case-incidence-and-vector-density-in-gujranwala-pakistan 0.8 https://infectiouscongress.com/program/scientific-program/2025/an-exploratory-qualitative-semi-structured-interview-study-exploring-acceptability-of-self-sampling-testing-for-blood-borne-viruses-in-the-south-asian-community-in-the-west-midlands-in-the-uk 0.8 https://infectiouscongress.com/program/scientific-program/2025/molnupiravir-and-covid-19-myopericarditis-an-indirect-therapeutic-role 0.8 https://infectiouscongress.com/program/scientific-program/2025/atypical-presentation-of-ocular-toxocariasis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2025/human-igg-responses-to-anopheles-gambiae-immunogenic-salivary-proteins-in-urban-and-rural-populations-of-burkina-faso-biomarkers-of-exposure-to-malaria-vector-bites 0.8 https://infectiouscongress.com/program/scientific-program/2025/from-awareness-to-action-enhancing-sepsis-screening-in-rural-hospitals-through-quality-improvement 0.8 https://infectiouscongress.com/program/scientific-program/2025/invasive-bloodstream-infection-caused-by-magnusiomyces-capitatus-case-report-with-clinical-review 0.8 https://infectiouscongress.com/program/scientific-program/2025/a-rare-presentation-of-spontaneous-necrotizing-fasciitis-of-the-thoracic-wall-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2025/brucellosis-presenting-as-chronic-back-pain 0.8 https://infectiouscongress.com/program/scientific-program/2025/the-state-of-oropouche-fever-a-review-of-clinical-presentations-and-viral-epidemiology 0.8 https://infectiouscongress.com/program/scientific-program/2025/rare-focal-infections-by-nontyphoidal-salmonella-a-case-series-of-unusual-presentations 0.8 https://infectiouscongress.com/program/scientific-program/2024/will-the-seine-river-water-jeopardize-the-athletes-health-during-the-sporting-events-of-the-2024-olympic-games-in-france 0.8 https://infectiouscongress.com/program/scientific-program/2024/assay-identifies-rvsv-g-zebov-gp-vaccination-status-and-correlates-ebola-virus-glycoprotein-with-vesicular-stomatitis-indiana-virus-nucleoprotein-antibodies 0.8 https://infectiouscongress.com/program/scientific-program/2024/efficacy-of-oral-20-hydroxyecdysone-bio101-in-adults-with-severe-covid-19-cova-a-randomized-placebo-controlled-phase-2-3-trial 0.8 https://infectiouscongress.com/program/scientific-program/2024/factors-affecting-the-outcomes-of-patients-with-coronavirus-disease-covid-19-admitted-in-a-tertiary-hospital-in-iloilo-city-a-retrospective-cross-sectional-study 0.8 https://infectiouscongress.com/program/scientific-program/2024/shiver-a-syphilis-hiv-test-and-treat-poct-intervention-trial-to-reach-rural-remote-and-underserved-populations-in-saskatchewan-canada 0.8 https://infectiouscongress.com/program/scientific-program/2024/an-ipsc-derived-organoid-based-model-of-intestinal-filovirus-infection 0.8 https://infectiouscongress.com/program/scientific-program/2024/hemophagocytic-lymphohistiocytosis-syndrome-and-syndrome-of-inappropriate-antidiuretic-hormone-adh-release-keep-in-mind-visceral-leishmaniasis-case-report-and-literature-review 0.8 https://infectiouscongress.com/program/scientific-program/2024/foreign-fungus-candida-duobushaemulonii-bloodstream-infection-in-an-immunocompromised-host-at-baguio-general-hospital-medical-center-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/implementing-the-covid-19-vaccination-programme-in-the-southwest-of-england-lessons-from-a-normalisation-process-theory-perspective 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-case-report-of-a-22-year-old-male-diagnosed-with-sle-with-concomitant-infections-of-covid-19-moderate-disease-and-hiv-aids 0.8 https://infectiouscongress.com/program/scientific-program/2024/an-unusual-case-of-multidrug-resistant-klebsiella-pneumoniae-and-vancomycin-resistant-enterococcus-faecium-skin-and-soft-tissue-infection-in-an-immunocompromised-host 0.8 https://infectiouscongress.com/program/scientific-program/2024/clinical-characteristics-and-outcomes-of-breakthrough-covid-19-infection-among-vaccinated-patients-admitted-in-a-tertiary-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2024/acinetobacter-baumannii-blaoxa-143-like-and-blaoxa-72-with-global-international-clone-ic-2-and-the-latin-america-endemic-ic5-exhibiting-strong-biofilm-formation-in-a-mexican-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2024/treatment-of-iron-deficiency-anemia-reduces-pneumonia-and-bacteremia-associated-hospitalizations 0.8 https://infectiouscongress.com/program/scientific-program/2024/use-of-intravenous-immunoglobulin-in-neonatal-enteroviral-sepsis 0.8 https://infectiouscongress.com/program/scientific-program/2024/low-volume-direct-multiplex-pcr-for-etiological-diagnosis-of-infectious-uveitis 0.8 https://infectiouscongress.com/program/scientific-program/2024/patterns-of-chlamydia-trachomatis-and-neisseria-gonorrhoeae-in-different-anatomical-sites-among-pre-exposure-prophylaxis-prpe-users-in-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2024/predictors-of-vaccination-rates-in-people-living-with-hiv-aids-followed-at-a-specialty-care-clinic-ribeirao-preto-sao-paulo-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2024/epidemiological-and-clinical-features-of-covid-19-among-the-pediatric-patients-admitted-in-the-zamboanga-city-medical-center-and-other-facilities-handling-covid-patients 0.8 https://infectiouscongress.com/program/scientific-program/2024/hav-ing-a-moment 0.8 https://infectiouscongress.com/program/scientific-program/2024/stability-and-disinfection-studies-for-risk-group-4-pathogens-improving-biosafety-measures-for-laboratories-and-patient-management 0.8 https://infectiouscongress.com/program/scientific-program/2024/establishment-of-a-human-lung-organoid-method-platform-for-infectious-disease-modelling 0.8 https://infectiouscongress.com/program/scientific-program/2024/diagnosis-of-neonatal-sepsis-using-a-rapid-lateral-flow-test-to-detect-serum-amyloid-a 0.8 https://infectiouscongress.com/program/scientific-program/2024/multi-omics-workflow-for-the-identification-of-discriminant-markers-associated-with-trypanosoma-cruzi-populations 0.8 https://infectiouscongress.com/program/scientific-program/2024/acute-hiv-infection-presenting-as-eczema-herpeticum-and-herpes-simplex-keratitis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/disseminated-echinococcus-infection-with-cardiopulmonary-involvement 0.8 https://infectiouscongress.com/program/scientific-program/2024/prevalence-of-co-infections-among-hospitalized-patients-with-covid-19-at-a-tertiary-care-hospital-muscat-oman-a-retrospective-study 0.8 https://infectiouscongress.com/program/scientific-program/2024/colonization-and-infection-in-admitted-patients-with-vancomycin-resistant-enterococcus-in-a-tertiary-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2024/ultrasound-for-diagnosing-pneumonia-the-place-of-the-blue-protocol 0.8 https://infectiouscongress.com/program/scientific-program/2024/clinical-characteristics-analysis-of-bordetella-pertussis-infection-in-adult-cough-patients 0.8 https://infectiouscongress.com/program/scientific-program/2024/antibiotic-resistance-of-enterococcus-spp-strains-isolated-from-wild-and-farm-animals-an-important-non-clinical-problem 0.8 https://infectiouscongress.com/program/scientific-program/2024/inflammation-adjusted-vitamin-a-deficiency-is-associated-with-higher-schistosoma-japonicum-infection-intensity-among-children-and-adolescents-in-the-philippines 0.8 https://infectiouscongress.com/program/scientific-program/2024/effect-of-a-multimodal-infection-control-programme-in-the-reduction-of-bacterial-contamination-in-the-nasogastric-feeding-tube-hubs-in-residential-care-homes-for-elders 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-power-of-cultural-validation-a-global-innovative-strategy-when-working-with-vaccines 0.8 https://infectiouscongress.com/program/scientific-program/2024/equine-polyclonal-f-ab-2-as-a-rapid-and-strong-therapeutic-answer-against-potential-new-sars-cov-2-surge 0.8 https://infectiouscongress.com/program/scientific-program/2024/implementing-an-electronic-screening-tool-to-improve-antimicrobial-prescribing-decision-making-for-paediatric-patients-with-suspected-sepsis-at-an-academic-hospital-in-england-a-before-and-after-study 0.8 https://infectiouscongress.com/program/scientific-program/2024/kluyvera-cryocrescens-central-line-associated-bacteremia-in-a-hemodialysis-patient-a-case-report-and-review-of-literature 0.8 https://infectiouscongress.com/program/scientific-program/2024/analysis-of-the-influence-of-the-covid-19-pandemic-on-reported-malaria-cases-in-brazilian-macroregions-between-2018-and-2022 0.8 https://infectiouscongress.com/program/scientific-program/2024/hhv6-encephalitis-in-an-immunocompetent-host 0.8 https://infectiouscongress.com/program/scientific-program/2024/an-effective-strategy-for-eliminating-chronic-hepatitis-c-in-individuals-with-an-opioid-addiction 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-new-insight-in-the-clinical-profile-of-indian-patients-of-urethritis-and-cervicitis-with-the-help-of-molecular-characterization-of-the-causative-organisms 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-fish-farmers-encounter-with-leptospirosis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/pheno-and-genotypic-characterization-of-enterococcus-spp-isolated-from-the-animal-farm-environments 0.8 https://infectiouscongress.com/program/scientific-program/2024/initial-sars-cov-2-infection-in-a-group-of-individuals-with-their-social-behavior 0.8 https://infectiouscongress.com/program/scientific-program/2024/severe-adenovirus-infection-in-an-immunocopemtment-host 0.8 https://infectiouscongress.com/program/scientific-program/2024/adapted-mrna-covid-19-vaccines-have-a-limited-ability-to-establish-herd-immunity-in-the-population-against-omicron-ba-1-and-ba4-5-variants-of-sars-cov-2 0.8 https://infectiouscongress.com/program/scientific-program/2024/factors-associated-with-non-adherence-to-tuberculosis-tb-preventive-treatment-among-adult-contacts-of-pulmonary-tb-cases-with-latent-tb-infection-in-spain 0.8 https://infectiouscongress.com/program/scientific-program/2024/to-identify-and-distinguish-cytokine-storms-based-on-manifestations-and-to-protect-human-from-infectious-disease-by-targeting-cytokines 0.8 https://infectiouscongress.com/program/scientific-program/2024/develop-the-overall-diagnosis-and-treatment-strategy-of-infectious-disease-epidemic-and-create-a-novel-precise-diagnosis-and-treatment-model-of-cytokine-storm 0.8 https://infectiouscongress.com/program/scientific-program/2024/dynamics-of-maternal-dengue-virus-antibodies-in-indian-infants 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-comparative-study-on-uroculturome-antimicrobial-susceptibility-in-apparently-healthy-and-urinary-tract-infected-humans 0.8 https://infectiouscongress.com/program/scientific-program/2024/isolation-of-staphylococcus-aureus-urinary-tract-infections-at-a-community-based-healthcare-center-in-riyadh 0.8 https://infectiouscongress.com/program/scientific-program/2024/clinical-use-of-azd7442-as-pre-exposure-prophylaxis-for-covid-19-in-the-real-world-setting-interim-analysis-of-the-evolve-study 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-impact-of-sars-cov2-pandemic-on-the-prevalence-and-the-outcome-of-candida-auris-infections-admitted-to-a-tertiary-hospital-in-united-arab-emirates-uae-in-2022 0.8 https://infectiouscongress.com/program/scientific-program/2024/ralstonia-pickettii-periprosthetic-joint-infection 0.8 https://infectiouscongress.com/program/scientific-program/2024/gram-negative-bacillary-arthritis-following-arthroscopy 0.8 https://infectiouscongress.com/program/scientific-program/2024/mechanisms-of-sars-cov-2-neurovirulence-in-chemosensory-dysfunction-and-prognosis-of-affected-patients-systematic-review 0.8 https://infectiouscongress.com/program/scientific-program/2024/an-unexpected-twist-under-the-microscope-schistosomiasis-masquerading-as-endometriosis 0.8 https://infectiouscongress.com/program/scientific-program/2024/uncharted-territory-in-mycobacterial-world-the-second-reported-case-of-mycobacterium-shimoidei-in-the-united-states 0.8 https://infectiouscongress.com/program/scientific-program/2024/evaluation-of-the-antifungal-activity-of-metabolites-produced-by-soil-actinomycetes-on-the-candida-species-isolated-from-candidemia 0.8 https://infectiouscongress.com/program/scientific-program/2024/determining-the-frequency-of-trichosporon-species-and-tracking-yeast-in-urine-clinical-samples-using-gold-nanoparticles 0.8 https://infectiouscongress.com/program/scientific-program/2024/rare-fungal-infection-in-chronic-lymphocytic-leukemia-scopulariopsis-as-a-clinical-challenge 0.8 https://infectiouscongress.com/program/scientific-program/2024/rec-3964-a-first-in-class-molecule-for-the-prevention-of-recurrent-clostridioides-difficile-infection 0.8 https://infectiouscongress.com/program/scientific-program/2024/advancing-sexual-health-education-a-methodological-triangulation-in-the-development-and-impact-of-the-dish-az-academic-detailing-program 0.8 https://infectiouscongress.com/program/scientific-program/2024/perspectives-of-obgyn-clinicians-on-integrating-prep-in-routine-women-s-health-care-a-qualitative-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2024/improved-techniques-for-validation-of-inactivated-virus-and-rna-of-positive-sense-rna-viruses-for-containment-research 0.8 https://infectiouscongress.com/program/scientific-program/2024/prevalence-of-covid-19-diagnosis-among-brazilian-nurses-after-complete-vaccination-schedule 0.8 https://infectiouscongress.com/program/scientific-program/2024/prevalence-of-physical-and-or-mental-health-symptoms-for-four-weeks-or-more-due-to-covid-19-among-brazilian-nurses 0.8 https://infectiouscongress.com/program/scientific-program/2024/catheter-related-atlantibacter-hermannii-sepsis-in-a-hemodialysis-patient 0.8 https://infectiouscongress.com/program/scientific-program/2024/when-dengue-disguises-itself-uncommon-presentation-resembling-hemophagocytic-lymphohistiocytosis-in-a-young-adult 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-presentation-of-rhabdomyolysis-in-influenza-b-patients-a-case-series 0.8 https://infectiouscongress.com/program/scientific-program/2024/early-versus-late-onset-necrotizing-enterocolitis-in-very-low-birth-infants-in-the-neonatal-intensive-care-unit 0.8 https://infectiouscongress.com/program/scientific-program/2024/assessing-hiv-1-drug-resistance-in-patients-with-virological-failure-amid-the-rollout-of-dolutegravir-in-hyperendemic-kwazulu-natal-south-africa 0.8 https://infectiouscongress.com/program/scientific-program/2024/sars-cov-2-omicron-nucleocapsid-effectively-suppresses-interferon-beta-expression-via-interaction-with-host-hspa4 0.8 https://infectiouscongress.com/program/scientific-program/2024/current-situation-of-cystic-echinococcosis-in-peru 0.8 https://infectiouscongress.com/program/scientific-program/2024/hepatitis-b-vaccination-uptake-and-associated-factors-among-communities-targeted-for-mass-vaccination-in-gulu-uganda 0.8 https://infectiouscongress.com/program/scientific-program/2024/immune-response-to-hepatitis-b-vaccination-among-children-under-5-in-a-highly-endemic-country-in-sub-saharan-africa-uganda 0.8 https://infectiouscongress.com/program/scientific-program/2024/does-switching-from-triple-or-quadruple-drug-regimen-to-double-drug-regimen-with-oral-instis-reduce-drug-related-adverse-events-draes-and-toxicity-in-virologically-suppressed-people-with-hiv-satisfaction-study 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-snapshot-of-a-representative-brazilian-state-of-illegal-mining-in-indigenous-areas-during-the-era-of-malaria-elimination 0.8 https://infectiouscongress.com/program/scientific-program/2024/five-year-profile-and-outcomes-of-pediatric-patients-diagnosed-with-tuberculosis-at-a-tertiary-hospital-in-makati-philippines-2016-2020 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-case-of-late-onset-prosthetic-valve-endocarditis-with-cerebral-thrombo-embolic-episodes-and-aseptic-meningitis 0.8 https://infectiouscongress.com/program/scientific-program/2024/an-unconventional-therapeutic-oligonucleotide-effectively-reduces-sars-cov-2-rna-levels-in-preclinical-animal-studies 0.8 https://infectiouscongress.com/program/scientific-program/2024/molecular-detection-and-charcterization-of-protoparvoviruses-in-bats-and-lion-in-ibadan-nigeria 0.8 https://infectiouscongress.com/program/scientific-program/2024/assessment-of-tick-diversity-and-potential-pathogen-transmission-in-two-ecological-niches-implications-for-zoonotic-disease-surveillance 0.8 https://infectiouscongress.com/program/scientific-program/2024/effective-reduction-of-sars-cov-2-rna-levels-in-transfected-lung-cells-using-a-tailor-made-therapeutic-oligonucleotide 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-rare-case-of-aortic-aspergillosis-in-an-immunocompetent-patient-with-no-pre-existing-cardiac-pathology-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/antimicrobial-activity-of-peptides-derived-from-lycosa-erythrognatha-spider-venom-against-quinolone-resistant-uropathogenic-escherichia-coli-upecs 0.8 https://infectiouscongress.com/program/scientific-program/2024/native-aortic-valve-endocarditis-secondary-to-streptococcus-gordonii-a-rare-presentation 0.8 https://infectiouscongress.com/program/scientific-program/2024/designing-a-pre-exposure-prophylaxis-prep-training-for-providers-to-increase-prep-awareness-and-prescription-for-black-cisgender-women 0.8 https://infectiouscongress.com/program/scientific-program/2024/pd-associated-peritonitis-a-case-first-for-aquamicrobium 0.8 https://infectiouscongress.com/program/scientific-program/2024/use-of-intravenous-immunoglobulin-in-neonatal-enteroviral-sepsis 0.8 https://infectiouscongress.com/program/scientific-program/2024/an-imitation-game-syphilis-infection-and-increased-odds-of-neurologic-morbidity 0.8 https://infectiouscongress.com/program/scientific-program/2024/peritoneal-coccidioidomycosis-presenting-as-treatment-resistant-tuberculosis 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-comparative-effectiveness-of-antipyretics-between-oral-paracetamol-and-intravenous-metamizole-in-fever-patient 0.8 https://infectiouscongress.com/program/scientific-program/2024/association-between-covid-19-infection-and-myocarditis 0.8 https://infectiouscongress.com/program/scientific-program/2024/incremental-value-of-an-ultra-rapid-phenotypic-antimicrobial-susceptibility-testing-in-patients-with-bloodstream-infection-a-modeling-approach 0.8 https://infectiouscongress.com/program/scientific-program/2024/carbapenemase-producing-multidrug-resistance-of-gram-negative-bacilli-causing-bacteremia-at-the-general-hospital-of-mexico 0.8 https://infectiouscongress.com/program/scientific-program/2024/clinical-features-of-adult-hospitalized-non-vaccinated-covid-19-patients-during-the-omicron-variant-surge-in-japan 0.8 https://infectiouscongress.com/program/scientific-program/2024/efficacy-and-safety-studies-of-ec16-nanoformulations-against-human-coronavirus 0.8 https://infectiouscongress.com/program/scientific-program/2024/clinical-significance-and-global-burden-of-antibiotic-resistance 0.8 https://infectiouscongress.com/program/scientific-program/2024/societal-factors-constraining-the-application-of-advances-in-biological-sciences-for-controlling-covid-19-and-mosquito-and-tick-borne-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2024/repercussions-of-pasteurella-multocida-infection-in-humans-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/diseminated-lyme-disease-a-rare-presentation-of-bilateral-optic-neuritis-and-sinus-bradycardia-without-any-conduction-defects 0.8 https://infectiouscongress.com/program/scientific-program/2024/abrupt-and-lethal-rare-complication-a-case-report-of-a-32-year-old-male-who-suffered-from-pyogenic-ventriculitis 0.8 https://infectiouscongress.com/program/scientific-program/2024/is-plasmapheresis-the-future-treatment-for-leptospirosis-case-report-of-a-75-year-old-patient-with-complete-recovery-after-plasmapheresis-therapy 0.8 https://infectiouscongress.com/program/scientific-program/2024/profiling-prescribing-patterns-and-infection-rates-among-inpatients-at-orthopedics-wards-prospective-interventional-implementation-study-amsp-piis 0.8 https://infectiouscongress.com/program/scientific-program/2024/repercussions-of-monkeypox-infection-in-humans-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/korea-seroprevalence-study-of-monitoring-of-sars-cov-2-antibody-retention-and-transmission-k-serosmart-a-community-based-longitudinal-seroprevalence-survey 0.8 https://infectiouscongress.com/program/scientific-program/2024/awareness-of-antimicrobial-resistance-evaluating-the-impact-of-a-foldscope-based-workshop 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-descriptive-epidemiology-of-adverse-events-following-two-doses-of-mrna-covid-19-vaccination-in-curacao 0.8 https://infectiouscongress.com/program/scientific-program/2024/immune-transcriptomic-analysis-of-covid-19-patients-with-varying-clinical-presentations 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-lived-experiences-of-hiv-positive-young-adults-regarding-adherence-to-antiretroviral-treatment-in-tshwane-district-gauteng 0.8 https://infectiouscongress.com/program/scientific-program/2024/epidemiological-aspects-of-rabies-in-an-amazon-cerrado-transition-region-of-northeastern-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2024/overcoming-the-challenges-of-drug-resistant-fungal-infections-in-developing-countries 0.8 https://infectiouscongress.com/program/scientific-program/2024/investigation-of-wild-canid-mediated-human-rabies-death-brazil-2021 0.8 https://infectiouscongress.com/program/scientific-program/2024/viral-profile-of-respiratory-infections-according-to-age-in-hospitals-in-brazzaville-republic-of-congo 0.8 https://infectiouscongress.com/program/scientific-program/2024/bacteria-or-kidney-stones-which-came-first 0.8 https://infectiouscongress.com/program/scientific-program/2024/story-of-the-wandering-worm 0.8 https://infectiouscongress.com/program/scientific-program/2024/rna-interference-its-applications-and-benefits 0.8 https://infectiouscongress.com/program/scientific-program/2024/assessing-covid-19-in-the-context-of-geopolitics 0.8 https://infectiouscongress.com/program/scientific-program/2024/pulmonary-manifestations-of-chronic-melioidosis-in-a-patient-with-type-2-diabetes-mellitus-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/clinical-characteristics-and-outcomes-of-pediatric-patients-with-suspected-and-confirmed-coronavirus-disease-2019-covid-19-infection-admitted-in-a-tertiary-government-hospital-in-the-philippines 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-mechanism-of-the-suppression-of-experimental-fungal-keratitis-by-histone-deacetylases-inhibitors 0.8 https://infectiouscongress.com/program/scientific-program/2024/investigation-of-molecular-epidemiology-of-carbapenem-resistant-acinetobacter-baumannii-group-in-taiwan 0.8 https://infectiouscongress.com/program/scientific-program/2024/a-case-of-disseminated-histoplasmosis-presenting-as-fever-of-unknown-origin-in-a-patient-with-diabetes-mellitus 0.8 https://infectiouscongress.com/program/scientific-program/2024/hiv-associated-vasculopathy-presenting-as-cerebrovascular-accident-in-a-young-girl-with-hiv 0.8 https://infectiouscongress.com/program/scientific-program/2024/the-role-of-epstein-barr-virus-in-upper-respiratory-tract-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2024/insights-into-west-nile-virus-seroprevalence-in-wild-birds-and-equines-a-focus-on-madrid-province-spain 0.8 https://infectiouscongress.com/program/scientific-program/2024/viral-pathogens-of-acute-gastroenteritis-in-egyptian-children-role-of-the-parechovirus 0.8 https://infectiouscongress.com/program/scientific-program/2024/unraveling-a-case-of-tubercular-thyroiditis-presenting-as-thyrotoxicosis 0.8 https://infectiouscongress.com/program/scientific-program/2024/risk-factors-for-bacterial-infection-in-children-following-liver-transplantation-in-indonesia-a-preliminary-study 0.8 https://infectiouscongress.com/program/scientific-program/2024/sustainable-soap-bars-delivering-skin-health-and-hygiene-benefits-for-infection-protection 0.8 https://infectiouscongress.com/program/scientific-program/2024/measles-outbreak-another-post-covid-phenomenon-lessons-to-be-learnt 0.8 https://infectiouscongress.com/program/scientific-program/2024/implementation-of-opt-out-human-immunodeficiency-virus-screening-in-pediatric-emergency-departments 0.8 https://infectiouscongress.com/program/scientific-program/2024/1-1-0-challenges-in-managing-early-lyme-disease-with-anaplasmosis-co-infection 0.8 https://infectiouscongress.com/program/scientific-program/2024/metabolic-reprogramming-of-kshv-infection-and-tumorigenesis 0.8 https://infectiouscongress.com/program/scientific-program/2024/ocular-syphilis-with-concomitant-neurosyphilis-and-tuberculosis-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2024/estimating-the-effectiveness-of-non-pharmaceutical-interventions-during-covid-19 0.8 https://infectiouscongress.com/program/scientific-program/2024/need-of-monitoring-human-papillomavirus-infection-among-oral-and-oropharyngeal-squamous-cell-carcinoma-patients-from-setting-with-high-incidence-of-cervical-cancer 0.8 https://infectiouscongress.com/program/scientific-program/2024/evaluation-of-the-clinical-effectiveness-of-an-early-marker-system-for-differentiating-between-viral-or-bacterial-respiratory-infections-or-febrile-infections-in-a-childrens-hospital-during-the-first-post-pandemic-season 0.8 https://infectiouscongress.com/program/scientific-program/2023/mva-based-virotherapies-in-the-treatment-of-infectious-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-rationale-of-ethanol-inhalation-for-disinfection-of-the-respiratory-tract-in-sars-cov-2-positive-asymptomatic-subjects 0.8 https://infectiouscongress.com/program/scientific-program/2023/progression-of-pneumococcal-nasopharynx-colonization-in-relation-to-the-pneumococcal-conjugate-vaccines-in-children-between-the-ages-of-2-months-to-5-years-at-boston-medical-center 0.8 https://infectiouscongress.com/program/scientific-program/2023/rapid-isothermal-detection-of-zika-virus-a-potential-alternative-to-rt-pcr 0.8 https://infectiouscongress.com/program/scientific-program/2023/no-cold-chain-molecular-workflow-for-detecting-and-differentiating-plasmodium 0.8 https://infectiouscongress.com/program/scientific-program/2023/carriage-of-neisseria-meningitidis-among-university-students-living-in-residential-colleges-dunedin-new-zealand 0.8 https://infectiouscongress.com/program/scientific-program/2023/therapeutic-intervention-of-bunyavirus-induced-hemorrhagic-fever-and-cardiopulmonary-disease 0.8 https://infectiouscongress.com/program/scientific-program/2023/insecticide-resistance-and-use-of-household-insecticides-for-personal-protection-insights-from-vector-borne-disease-outbreaks 0.8 https://infectiouscongress.com/program/scientific-program/2023/efficacy-and-safety-of-inhalation-of-nebulized-ethanol-in-covid-19-treatment-a-randomized-clinical-trial 0.8 https://infectiouscongress.com/program/scientific-program/2023/spatio-temporal-patterns-of-dengue-incidence-and-their-associated-factors-brazil-2000-2018 0.8 https://infectiouscongress.com/program/scientific-program/2023/molecular-screening-for-intestinal-protozoan-and-fungal-pathogens-and-first-subtyping-of-blastocystis-spp-in-hemodialysis-patients-in-slovakia 0.8 https://infectiouscongress.com/program/scientific-program/2023/inhibitory-effects-of-limonene-on-candida-albicans-virulence-related-traits 0.8 https://infectiouscongress.com/program/scientific-program/2023/onchocerciasis-drug-development-from-pre-clinicals-to-humans 0.8 https://infectiouscongress.com/program/scientific-program/2023/diagnosis-of-suspicious-skin-lesions-in-mpox-times 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-burden-of-human-parechoviruses-on-children-in-oman 0.8 https://infectiouscongress.com/program/scientific-program/2023/clinical-evaluation-of-mpox-virus-detection-by-real-time-pcr 0.8 https://infectiouscongress.com/program/scientific-program/2023/sternal-wound-infection-following-open-heart-surgery-incidence-risk-factor-pathogen-and-mortality 0.8 https://infectiouscongress.com/program/scientific-program/2023/predicted-coverage-by-4cmenb-and-menb-fhbp-vaccine-against-invasive-serogroup-b-neisseria-meningitidis-isolated-from-2017-2019-in-lithuania 0.8 https://infectiouscongress.com/program/scientific-program/2023/effect-of-dietary-intervention-on-the-prevalence-of-asymptomatic-malaria-among-6-18-month-old-children-in-rural-malawi 0.8 https://infectiouscongress.com/program/scientific-program/2023/engystol-may-reduce-lung-pathology-in-sars-cov-2-infected-hamsters-a-pilot-study 0.8 https://infectiouscongress.com/program/scientific-program/2023/comparing-climatic-and-socioeconomic-factors-inside-and-outside-the-high-risk-spatial-clusters-of-chikungunya-and-zika-in-brazil 0.8 https://infectiouscongress.com/program/scientific-program/2023/exploring-the-impact-of-plectranthus-amboinicus-l-extracts-on-antioxidant-system-and-cell-membrane-integrity-of-p-aeruginosa-pa01-and-s-aureus-nctc8325 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-potential-of-guanidino-and-amidopropyl-dimethylamine-compounds-as-topical-treatments-for-diabetic-foot-ulcer-infections 0.8 https://infectiouscongress.com/program/scientific-program/2023/chikungunya-and-zika-high-risk-co-occurrence-clusters-in-brazil-is-there-a-perfect-overlap 0.8 https://infectiouscongress.com/program/scientific-program/2023/development-of-a-syndromic-molecular-diagnostic-assay-using-barcoded-magnetic-bead-technology-for-tick-borne-pathogens 0.8 https://infectiouscongress.com/program/scientific-program/2023/lack-of-association-between-yeastone-antifungal-susceptibility-of-cryptococcus-meningitis-cerebrospinal-fluid-isolates-and-risk-factors-for-poor-prognosis 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-activity-of-phmb-and-other-guanidino-containing-compounds-against-acanthamoeba 0.8 https://infectiouscongress.com/program/scientific-program/2023/investigation-of-the-immunomodulatory-effects-of-cecropin-a-on-a-primary-hepatic-coculture-of-chicken-origin 0.8 https://infectiouscongress.com/program/scientific-program/2023/screening-the-medicines-for-malaria-venture-mmv-pandemic-response-box-chemical-library-on-caenorhabditis-elegans-identifies-re-profiled-candidate-anthelmintic-drug-leads 0.8 https://infectiouscongress.com/program/scientific-program/2023/concept-elicitation-cognitive-debriefing-and-usability-testing-of-covid-symptoms-diary 0.8 https://infectiouscongress.com/program/scientific-program/2023/advancing-infection-control-and-pressure-ulcer-prevention-developing-an-innovative-antibacterial-pajama-with-dual-benefits 0.8 https://infectiouscongress.com/program/scientific-program/2023/phage-therapy-in-clinical-practice-experience-in-chronic-bone-infections 0.8 https://infectiouscongress.com/program/scientific-program/2023/essential-functions-of-rna-virus-genome-beyond-the-storage-of-protein-coding-information 0.8 https://infectiouscongress.com/program/scientific-program/2023/comparisons-of-the-molnupiravir-sotrovimab-and-remdesivir-use-for-covid-19-patients-in-a-tertiary-hospital-of-japan 0.8 https://infectiouscongress.com/program/scientific-program/2023/quality-control-of-infectious-disease-testing 0.8 https://infectiouscongress.com/program/scientific-program/2023/quality-control-of-infectious-disease-testing 0.8 https://infectiouscongress.com/program/scientific-program/2023/applications-and-prospects-of-metagenomics-in-fish-gut-microbiota-research 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-role-of-novel-cold-atmospheric-plasma-technology-in-preventing-infectious-diseases 0.8 https://infectiouscongress.com/program/scientific-program/2023/potential-of-lactobacillus-plantarum-in-amelioration-of-lps-induced-infertility-in-mouse-model 0.8 https://infectiouscongress.com/program/scientific-program/2023/selection-underlying-evolution-and-spread-of-sars-cov-2-variants 0.8 https://infectiouscongress.com/program/scientific-program/2023/novel-nasal-formulations-containing-ec16-to-combat-long-covid 0.8 https://infectiouscongress.com/program/scientific-program/2023/novel-functions-of-irf3-in-viral-infection-and-inflammation 0.8 https://infectiouscongress.com/program/scientific-program/2023/higher-proportion-of-sars-cov-2-positive-children-vs-adults-detected-as-early-as-four-mounts-after-the-outbreak-of-2020-covid-19-pandemic-in-warsaw-poland 0.8 https://infectiouscongress.com/program/scientific-program/2023/characteristics-of-healthcare-workers-infected-with-covid-19-a-retrospective-descriptive-study-in-a-university-hospital-jeddah-saudi-arabia 0.8 https://infectiouscongress.com/program/scientific-program/2023/specific-igy-antibodies-protect-syrian-hamsters-against-sars-cov-2-infection 0.8 https://infectiouscongress.com/program/scientific-program/2023/level-of-vaccination-against-covid-19-and-post-vaccination-breakthrough-infection-among-a-cohort-of-healthcare-workers-in-a-tertiary-teaching-hospital-in-ethiopia 0.8 https://infectiouscongress.com/program/scientific-program/2023/co-infection-of-severe-leptospirosis-and-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-with-multiple-organ-involvement-in-indonesia 0.8 https://infectiouscongress.com/program/scientific-program/2023/barriers-to-antiretroviral-medication-adherence-in-people-living-with-hiv-plhiv-at-the-time-of-covid-19-pandemic-in-the-philippines 0.8 https://infectiouscongress.com/program/scientific-program/2023/are-your-nasopharyngeal-swabs-stored-in-good-condition 0.8 https://infectiouscongress.com/program/scientific-program/2023/characterisation-of-the-proteomic-response-of-candida-parapsilosis-to-the-silver-i-compound-sbc3 0.8 https://infectiouscongress.com/program/scientific-program/2023/microbial-adhesion-capacity-on-orthopedic-implants 0.8 https://infectiouscongress.com/program/scientific-program/2023/to-develop-an-overall-diagnosis-and-treatment-strategy-to-the-epidemic-situation-of-infectious-diseases-and-establish-an-innovative-medical-model-for-precise-diagnosis-and-treatment-of-cytokine-storm 0.8 https://infectiouscongress.com/program/scientific-program/2023/to-develop-an-overall-diagnosis-and-treatment-strategy-to-the-epidemic-situation-of-infectious-diseases-and-establish-an-innovative-medical-model-for-precise-diagnosis-and-treatment-of-cytokine-storm 0.8 https://infectiouscongress.com/program/scientific-program/2023/leptospirosis-in-rural-colombia-moniquira-s-case-series-in-2022 0.8 https://infectiouscongress.com/program/scientific-program/2023/tuberculosis-meningoencephalitis-and-drug-side-effects-the-important-role-of-early-diagnosis-and-therapy-modification-for-better-outcome-in-indonesia 0.8 https://infectiouscongress.com/program/scientific-program/2023/clinico-epidemiological-presentation-of-acute-encephalitis-syndrome-in-patients-visiting-a-tertiary-hospital-in-kathmandu-nepal-a-descriptive-cross-sectional-study 0.8 https://infectiouscongress.com/program/scientific-program/2023/antibiotic-resistant-strains-of-klebsiella-pneumoniae-harbouring-novel-virulence-proteins-with-rising-temperature 0.8 https://infectiouscongress.com/program/scientific-program/2023/have-the-gambia-met-the-enrolment-target-for-hiv-the-gambia-2017-2021 0.8 https://infectiouscongress.com/program/scientific-program/2023/molecular-diagnostics-in-critically-ill-patients-with-severe-pneumonia 0.8 https://infectiouscongress.com/program/scientific-program/2023/research-on-the-mental-health-of-medical-interns-in-clinical-teaching-base-in-the-post-pandemic-era-data-from-china 0.8 https://infectiouscongress.com/program/scientific-program/2023/determinants-of-early-virologic-failure-among-hiv-patients-on-first-line-anti-retroviral-therapy 0.8 https://infectiouscongress.com/program/scientific-program/2023/bacterial-co-infection-and-secondary-infection-in-sars-cov-2-covid-19-adult-patients-in-a-national-tertiary-infectious-disease-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2023/burden-of-invasive-group-b-streptococcus-infection-among-infants-less-than-90-day-old-in-oman-a-multicentre-study 0.8 https://infectiouscongress.com/program/scientific-program/2023/facial-pressure-ulcers-incidence-within-pandemic-in-critical-care-depts-are-there-feasible-strategies-to-prevent-this-complication 0.8 https://infectiouscongress.com/program/scientific-program/2023/in-vitro-whole-leukocyte-infection-model-and-detection-of-hydrophobic-surface-binding-protein-a-hsba-in-l-corymbidera 0.8 https://infectiouscongress.com/program/scientific-program/2023/identification-of-micrornas-dysregulated-in-sars-cov-2-infected-patients-in-the-ethnically-diverse-population-of-the-united-arab-emirates-uae 0.8 https://infectiouscongress.com/program/scientific-program/2023/updates-in-covid-19-laboratory-diagnosis 0.8 https://infectiouscongress.com/program/scientific-program/2023/covid-19-in-the-homeless-population-a-scoping-review-and-meta-analysis-examining-differences-in-prevalence-presentation-vaccine-hesitancy-and-government-response-in-the-first-year-of-the-pandemic 0.8 https://infectiouscongress.com/program/scientific-program/2023/covid-19-in-the-homeless-population-a-scoping-review-and-meta-analysis-examining-differences-in-prevalence-presentation-vaccine-hesitancy-and-government-response-in-the-first-year-of-the-pandemic 0.8 https://infectiouscongress.com/program/scientific-program/2023/measles-sans-rash-an-atypical-cause-of-new-onset-refractory-status-epilepticus-norse 0.8 https://infectiouscongress.com/program/scientific-program/2023/neutrophils-novel-contributors-to-estrogen-dependent-intracranial-aneurysm-rupture-via-neutrophil-extracellular-traps 0.8 https://infectiouscongress.com/program/scientific-program/2023/anticoronavirus-formulations-based-on-chitosan 0.8 https://infectiouscongress.com/program/scientific-program/2023/dengue-transmission-and-aedes-vector-dynamics-before-during-and-after-covid-19-travel-restrictions 0.8 https://infectiouscongress.com/program/scientific-program/2023/amplicon-sequencing-method-for-strain-level-subtyping-of-bacillus-anthracis-in-field-laboratory 0.8 https://infectiouscongress.com/program/scientific-program/2023/mobilizing-the-private-sector-resources-for-a-strengthened-covid-19-response 0.8 https://infectiouscongress.com/program/scientific-program/2023/an-evolutionary-view-of-the-coronavirus-epidemic-process 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-prevalence-of-covid-19-infection-in-patients-presented-with-acute-exacerbation-of-asthma-copd-and-idiopathic-pulmonary-fibrosis-at-the-emergency-department-of-al-shaab-teaching-hospital-from-july-2021-to-november-2021 0.8 https://infectiouscongress.com/program/scientific-program/2023/treatment-of-old-world-cutaneous-leishmaniasis-with-paromomycin-cream-oral-dapsone-alone-and-in-combination-in-algabal-algarby-libya 0.8 https://infectiouscongress.com/program/scientific-program/2023/use-of-tixagevimab-cilgavimab-in-omicron-outbreak-in-china-baseline-characteristics-and-interim-analysis-of-the-clinical-outcomes 0.8 https://infectiouscongress.com/program/scientific-program/2023/a-strong-dominance-in-the-spread-of-influenza-viruses-over-that-of-the-sars-cov-2-during-the-2022-2023-season-in-bulgaria 0.8 https://infectiouscongress.com/program/scientific-program/2023/prevalence-and-characteristics-of-neisseria-meningitidis-carriage-among-high-school-students-from-the-vilnius-region-lithuania 0.8 https://infectiouscongress.com/program/scientific-program/2023/profile-of-beta-lactamases-in-multidrug-resistant-mdr-acinetobacter-baumannii-strains-in-lithuania-2016-2017-and-2021-2022-years 0.8 https://infectiouscongress.com/program/scientific-program/2023/the-role-of-aedes-koreicus-in-the-circulation-of-dirofilaria-repens-and-dirofilaria-immitis-filarial-nematodes-in-a-middle-sized-european-city-in-hungary 0.8 https://infectiouscongress.com/program/scientific-program/2023/cd11c-dendritic-cells-are-required-for-survival-in-murine-lps-induced-ali 0.8 https://infectiouscongress.com/program/scientific-program/2023/identification-of-novel-p-falciparum-kelch13-pfk13-interacting-partners-via-coimmunoprecipitation-co-ip 0.8 https://infectiouscongress.com/program/scientific-program/2023/evaluation-of-the-national-immunization-program-by-estimating-immunoglobulin-g-antibody-prevalence-of-measles-and-rubella-in-lao-peoples-democratic-republic 0.8 https://infectiouscongress.com/program/scientific-program/2023/analysis-of-oral-clinical-manifestations-and-serological-test-results-of-secondary-syphilis 0.8 https://infectiouscongress.com/program/scientific-program/2023/effect-of-a-novel-anti-splash-mask-on-preventing-aerosol-in-dental-practice 0.8 https://infectiouscongress.com/program/scientific-program/2023/development-of-novel-vaccine-adjuvant-formulation-against-ibv-for-the-poultry-industry 0.8 https://infectiouscongress.com/program/scientific-program/2023/culture-proven-bloodstream-infection-in-children-managed-at-a-tertiary-hospital-in-oman 0.8 https://infectiouscongress.com/program/scientific-program/2023/metabolic-predictors-of-covid-19-mortality-and-severity-a-survival-analysis-study 0.8 https://infectiouscongress.com/program/scientific-program/2023/three-year-retrospective-study-on-the-survival-analysis-of-ventilator-acquired-pneumonia-adult-patients-at-batangas-medical-center-philippines 0.8 https://infectiouscongress.com/program/scientific-program/2023/in-vitro-activity-of-colistin-against-pseudomonas-aeruginosa-with-difficult-to-treat-resistance-isolates-from-critically-ill-burn-patients 0.8 https://infectiouscongress.com/program/scientific-program/2023/integration-of-immunoinformatics-and-cheminformatics-to-design-and-evaluate-a-multitope-vaccine-against-klebsiella-pneumoniae-and-pseudomonas-aeruginosa-coinfection 0.8 https://infectiouscongress.com/program/scientific-program/2023/use-of-modified-brixia-score-in-predicting-mortality-in-hospitalized-patients-with-covid-19-pneumonia 0.8 https://infectiouscongress.com/program/scientific-program/2023/piringer-kuchinka-s-lymphadenitis-revealing-visceral-leishmaniasis-in-an-immunocompetent-a-case-report 0.8 https://infectiouscongress.com/program/scientific-program/2023/sars-cov2-viral-load-and-replication-in-postmortem-pulmonary-and-extrapulmonary-tissues 0.8 https://infectiouscongress.com/program/scientific-program/2023/molecular-identification-of-babesia-and-borrelia-species-that-are-potential-cause-of-babebiosis-and-lyme-disease-a-one-health-concept-study-of-wild-ticks 0.8 https://infectiouscongress.com/program/scientific-program/2023/osteoarticular-brucellosis-in-an-endemic-region-epidemio-clinical-aspects-diagnosis-and-treatment-of-49-cases 0.8 https://infectiouscongress.com/program/scientific-program/2023/therapeutic-challenges-of-cryptococcosis-in-immunocompetent-and-people-living-with-hiv-in-boufarik-alegria-a-retrospective-analysis 0.8 https://infectiouscongress.com/program/scientific-program/2022/improved-diagnosis-and-treatment-of-visceral-leishmaniasis 0.8 https://infectiouscongress.com/program/scientific-program/2022/novel-formulations-containing-ec16-for-future-antiviral-and-virucidal-products 0.8 https://infectiouscongress.com/program/scientific-program/2022/report-of-47-clinical-cases-of-dogs-with-viral-disease-parvovirus-and-canine-distemper-treated-with-silver-nanoparticles-at-the-biofauna-veterinary-polyclinic-in-ac-mbaro-guanajuato-mexico 0.8 https://infectiouscongress.com/program/scientific-program/2022/role-of-dicer-in-the-pathogenesis-of-hbv-associated-hepatocellular-carcinoma 0.8 https://infectiouscongress.com/program/scientific-program/2022/effect-of-motivational-interviewing-based-on-recovery-thrive-model-on-post-traumatic-growth-in-patients-with-liver-cancer-after-hepatitis-b-a-randomized-controlled-study 0.8 https://infectiouscongress.com/program/scientific-program/2022/covid-19-and-pregnancy-vaccination-challenges-and-concerns 0.8 https://infectiouscongress.com/program/scientific-program/2022/twelve-12-contacts-to-an-index-rifampicin-resistant-tb-patient-diagnosed-with-tb-a-case-of-mazabuka-zambia 0.8 https://infectiouscongress.com/program/scientific-program/2022/exploring-the-plant-derived-natural-antimetabolites-against-pathogenic-bacteria-in-silico-approaches-of-drug-discovery-in-combating-bacterial-infection-to-humans 0.8 https://infectiouscongress.com/program/scientific-program/2022/adherence-physical-limitation-and-social-participation-in-leprosy-patients-in-a-high-complexity-hospital 0.8 https://infectiouscongress.com/program/scientific-program/2022/early-onset-neonatal-sepsis 0.8 https://infectiouscongress.com/program/scientific-program/2022/covid-19-fungal-infections 0.8 https://infectiouscongress.com/program/scientific-program/2022/predictors-of-treatment-outcome-among-drug-resistant-tuberculosis-patient-at-the-outpatient-tb-dots-facility-of-zamboanga-city-medical-center 0.8 https://infectiouscongress.com/program/scientific-program/2022/indian-medicinal-phytoextracts-to-tackle-multi-drug-resistant-bacterial-infections-targeting-rna-polymerase-and-dna-topoisomerase 0.8 https://infectiouscongress.com/program/scientific-program/2022/periodontitis-and-adverse-pregnancy-outcomes-a-possible-link 0.8 https://infectiouscongress.com/program/scientific-program/2022/dependency-or-interdependency-effect-of-the-corona-virus-evidence-of-adcc-and-copula-multivariate-garch-models 0.8 https://infectiouscongress.com/program/scientific-program/2022/maxillary-mucormycosis-treated-by-maxillectomy-a-complication-of-oroantral-fistula-6-months-post-surgery-planned-for-functional-endoscopic-sinus-surgery-fess-and-palatal-finger-flap-reconstruction 0.8 https://infectiouscongress.com/program/scientific-program/2022/prevalence-of-rifampicin-resistance-in-pediatric-tuberculosis-cases-in-rural-area-of-north-india 0.8 https://infectiouscongress.com/program/scientific-program/2022/osteomyelitis-in-pediatric-burn-patients-in-a-pediatric-burn-unit-from-argentina 0.8 https://infectiouscongress.com/program/scientific-program/2022/molecular-study-of-norovirus-in-pediatric-patients-with-gastroenteritis 0.8 https://infectiouscongress.com/program/scientific-program/2022/overview-of-urinary-tract-infections-utis-in-adults-in-five-arabian-gulf-countries 0.8 https://infectiouscongress.com/program/scientific-program/2022/overview-of-intra-abdominal-infections-in-five-gulf-countries 0.8 https://infectiouscongress.com/program/scientific-program/2022/prevalence-of-vibrio-sp-in-farmed-shrimp-and-application-of-probiotics-as-a-possible-strategy-for-the-prevention-and-treatment 0.8 https://infectiouscongress.com/program/scientific-program/2022/effect-of-ozone-on-hematological-parameters 0.8 https://infectiouscongress.com/program/scientific-program/2022/changing-microbiota-in-hospitalized-patients-increase-the-covid-19-severity-a-possible-cause-of-developing-the-dysregulated-immune-response-a-literature-study 0.8 https://infectiouscongress.com/program/scientific-program/2022/pathogenesis-of-sars-cov-2-mycobacterium-tuberculosis-coinfection-their-prevention-and-treatment 0.8 https://infectiouscongress.com/program/scientific-program/2022/urinary-tract-infections-a-persisting-public-health-concern 0.8 https://infectiouscongress.com/program/scientific-program/2022/multidrug-resistance-in-burn-patients 0.8 https://infectiouscongress.com/program/scientific-program/2022/whole-genome-sequencing-and-comparative-analysis-of-indian-race-4-of-xanthomonas-campestris-pv-campestris-causing-black-rot-disease-in-brassica-oleracea-var-capitata 0.8 https://infectiouscongress.com/program/scientific-program/2022/covid-19-associated-fungal-infections-due-to-the-disturbance-in-infection-control-measures 0.8 https://infectiouscongress.com/program/scientific-program/2022/rare-atypical-subcutaneous-fungal-infections 0.8 https://infectiouscongress.com/program/scientific-program/2022/clinical-and-cytokine-profile-in-type-2-reaction-in-leprosy-in-response-to-thalidomide-a-randomized-controlled-trial 0.8 https://infectiouscongress.com/program/scientific-program/2022/post-covid-19-syndrome-in-jordan 0.8 https://infectiouscongress.com/program/scientific-program/2022/clinical-exposure-and-methicillin-resistant-staphylococcus-aureus-mrsa-colonization-among-medical-students-rajarata-university-of-sri-lanka 0.8 https://infectiouscongress.com/program/scientific-program/2022/five-year-prevalence-of-hospital-acquired-blood-stream-infections-in-a-tertiary-hospital-in-oman-a-cross-sectional-study 0.8 https://infectiouscongress.com/program/scientific-program/2022/prevalence-cholera-during-juanary-december-2020in-hudiedah-city-yemen 0.8 https://infectiouscongress.com/program/scientific-program/2022/effects-of-epigallocatechin-3-gallate-palmitate-ec16-on-in-vitro-norovirus-infection 0.8 https://infectiouscongress.com/program/scientific-program/2022/predictors-of-adherence-to-covid-19-prevention-measure-among-communities-in-north-shoa-zone-ethiopia-based-on-health-belief-model-a-cross-sectional-study 0.8 https://infectiouscongress.com/program/scientific-program/2022/probiotic-properties-of-bacillus-strains-isolated-from-gastrointestinal-tract-against-pathogenic-vibriosis 0.8 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/coronavirus-disease-covid-19 0.9 https://infectiouscongress.com/program/scientific-sessions/pediatric-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/std-and-hiv-infection 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases-prevention-control-and-cure 0.9 https://infectiouscongress.com/program/scientific-sessions/infection-immunity-and-inflammation 0.9 https://infectiouscongress.com/program/scientific-sessions/pharmacology-of-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/blood-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/epidemiology 0.9 https://infectiouscongress.com/program/scientific-sessions/sepsis-septicemia 0.9 https://infectiouscongress.com/program/scientific-sessions/ebola-and-zika-viral-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/emerging-and-re-emerging-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-resistance-amr 0.9 https://infectiouscongress.com/program/scientific-sessions/vaccine-development-and-immunization 0.9 https://infectiouscongress.com/program/scientific-sessions/global-health-and-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-infections-and-virology 0.9 https://infectiouscongress.com/program/scientific-sessions/genomics-and-bioinformatics-in-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases-diagnostics-and-imaging 0.9 https://infectiouscongress.com/program/scientific-sessions/infection-control-and-hospital-acquired-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases-and-aging 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases-and-public-health 0.9 https://infectiouscongress.com/program/scientific-sessions/innovative-therapies-and-drug-discovery 0.9 https://infectiouscongress.com/program/scientific-sessions/artificial-intelligence-and-big-data-in-infectious-disease-management 0.9 https://infectiouscongress.com/program/scientific-sessions/behavioral-and-social-aspects-of-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/non-communicable-diseases-and-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/emerging-technologies-in-infectious-disease-management 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases-and-neurology 0.9 https://infectiouscongress.com/program/scientific-sessions/clinical-case-reports 0.9 https://infectiouscongress.com/program/scientific-sessions/pandemic-preparedness-global-strategies-for-mitigation-and-response 0.9 https://infectiouscongress.com/program/scientific-sessions/airborne-waterborne-and-foodborne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-diseases-in-immunocompromised-hosts 0.9 https://infectiouscongress.com/program/scientific-sessions/one-health-approach-to-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/veterinary-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/tropical-and-neglected-tropical-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/early-symptoms-of-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-disease-research 0.9 https://infectiouscongress.com/program/scientific-sessions/climate-change-and-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/subclinical-and-asymptomatic-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-fungal-and-parasitic-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/research-on-medicine-and-vaccine-for-covid-19 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/parasitology-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/causes-and-symptoms-of-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/vaccines-and-vaccination 0.9 https://infectiouscongress.com/program/scientific-sessions/nosocomial-infections-control 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/veterinary-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/fungal-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/tropical-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/neuro-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/internal-medicine-for-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/clinical-and-case-reports 0.9 https://infectiouscongress.com/program/scientific-sessions/plants-diseases-and-fungal-infection-control 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobials-antibiotics-antibacterial 0.9 https://infectiouscongress.com/program/scientific-sessions/market-analysis-of-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/orthopaedic-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/non-communicable-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/problems-in-infectious-disease-practice 0.9 https://infectiouscongress.com/program/scientific-sessions/viruses-and-cancer 0.9 https://infectiouscongress.com/program/scientific-sessions/critical-care-and-its-applications 0.9 https://infectiouscongress.com/program/scientific-sessions/respiratory-syncytial-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/abacavir 0.9 https://infectiouscongress.com/program/scientific-sessions/abdominal-infection 0.9 https://infectiouscongress.com/program/scientific-sessions/acanthamoeba-infection 0.9 https://infectiouscongress.com/program/scientific-sessions/acanthamoeba-keratitis-infection 0.9 https://infectiouscongress.com/program/scientific-sessions/acyclovir 0.9 https://infectiouscongress.com/program/scientific-sessions/acinetobacter-infection 0.9 https://infectiouscongress.com/program/scientific-sessions/acinetobacter-species 0.9 https://infectiouscongress.com/program/scientific-sessions/acquired-immunodeficiency-syndrome 0.9 https://infectiouscongress.com/program/scientific-sessions/actinomyces-gerencseriae 0.9 https://infectiouscongress.com/program/scientific-sessions/actinomyces-israelii 0.9 https://infectiouscongress.com/program/scientific-sessions/acute-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/acute-rheumatic-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/acute-upper-respiratory-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/adefovir 0.9 https://infectiouscongress.com/program/scientific-sessions/adenovirus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/adult-non-flu-vaccines 0.9 https://infectiouscongress.com/program/scientific-sessions/aetiological-agent 0.9 https://infectiouscongress.com/program/scientific-sessions/african-sleeping-sickness 0.9 https://infectiouscongress.com/program/scientific-sessions/african-trypanosomiasis 0.9 https://infectiouscongress.com/program/scientific-sessions/aids-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/airborne-transmission 0.9 https://infectiouscongress.com/program/scientific-sessions/allergic-respiratory-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/alphavirus 0.9 https://infectiouscongress.com/program/scientific-sessions/alveolar-echinococcosis 0.9 https://infectiouscongress.com/program/scientific-sessions/amantadine 0.9 https://infectiouscongress.com/program/scientific-sessions/amebic-liver-abscess 0.9 https://infectiouscongress.com/program/scientific-sessions/amoebiasis 0.9 https://infectiouscongress.com/program/scientific-sessions/anti-infective-therapies 0.9 https://infectiouscongress.com/program/scientific-sessions/anti-viral-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/antibiotic-resistance 0.9 https://infectiouscongress.com/program/scientific-sessions/antibiotics-for-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/antifungals 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobials 0.9 https://infectiouscongress.com/program/scientific-sessions/antiprotozoans 0.9 https://infectiouscongress.com/program/scientific-sessions/antiretroviral-therapies 0.9 https://infectiouscongress.com/program/scientific-sessions/antiviral-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/antiviral-drugs 0.9 https://infectiouscongress.com/program/scientific-sessions/antiviral-responses 0.9 https://infectiouscongress.com/program/scientific-sessions/arbovirus 0.9 https://infectiouscongress.com/program/scientific-sessions/arenavirus 0.9 https://infectiouscongress.com/program/scientific-sessions/argentine-hemorrhagic-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/arthropod-borne-viruses 0.9 https://infectiouscongress.com/program/scientific-sessions/aspergillus 0.9 https://infectiouscongress.com/program/scientific-sessions/astrovirus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/attenuated-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/bacillus-species 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-gastroenteritis 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-meningitis 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-pneumonia 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-vaccines 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-vaginosis 0.9 https://infectiouscongress.com/program/scientific-sessions/bacteriophages 0.9 https://infectiouscongress.com/program/scientific-sessions/balantidium-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/bartonella-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/baylisascaris-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/bed-bugs 0.9 https://infectiouscongress.com/program/scientific-sessions/beta-lactam-antibiotic 0.9 https://infectiouscongress.com/program/scientific-sessions/bladder-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/blastocystosis 0.9 https://infectiouscongress.com/program/scientific-sessions/blastomycosis 0.9 https://infectiouscongress.com/program/scientific-sessions/bloodstream-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/body-lice-infestations 0.9 https://infectiouscongress.com/program/scientific-sessions/bolivian-hemorrhagic-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/bone-and-joint-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/botulinum-toxin-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/bourbon-virus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/brucella-species 0.9 https://infectiouscongress.com/program/scientific-sessions/campylobacter-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/candida-albicans 0.9 https://infectiouscongress.com/program/scientific-sessions/capillaria-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/cardiovascular-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/cat-scratch-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/catheter-related-urinary-tract-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/chickenpox 0.9 https://infectiouscongress.com/program/scientific-sessions/chikungunya 0.9 https://infectiouscongress.com/program/scientific-sessions/childhood-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/chlamydia-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/chronic-obstructive-pulmonary-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/climatic-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/cns-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/communicable-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/complicated-pulmonary-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/contagious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/cutaneous-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/cyclospora-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/cytomegalovirus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/deltaretrovirus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/dengue-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/directly-transmitted-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/drug-resistant-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/ear-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/ebola-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/emerging-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/epizootic-haemorrhagic-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/escherichia-coli-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/etiologic-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/exogenous-retroviruses 0.9 https://infectiouscongress.com/program/scientific-sessions/eye-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/fasciolopsis-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/fatal-epidemic-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/female-sexually-transmitted-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/foodborne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/fungal-endophthalmitis 0.9 https://infectiouscongress.com/program/scientific-sessions/fungal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/fungal-keratitis 0.9 https://infectiouscongress.com/program/scientific-sessions/fungal-sinusitis 0.9 https://infectiouscongress.com/program/scientific-sessions/fungal-vaccines 0.9 https://infectiouscongress.com/program/scientific-sessions/gastroenteritis 0.9 https://infectiouscongress.com/program/scientific-sessions/gastrointestinal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/genital-warts 0.9 https://infectiouscongress.com/program/scientific-sessions/genitourinary-tract-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/genomic-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/germ-theory-of-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/german-measles 0.9 https://infectiouscongress.com/program/scientific-sessions/gnathostoma-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/gonococcal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/gonorrhoea 0.9 https://infectiouscongress.com/program/scientific-sessions/green-algae 0.9 https://infectiouscongress.com/program/scientific-sessions/group-a-streptococcal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/group-b-streptococcal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/haemophilus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/haemorrhagic-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/hantavirus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/helicobacter-pylori-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/hemorrhagic-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/hendra-virus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/hepatitis-b 0.9 https://infectiouscongress.com/program/scientific-sessions/hepatitis-c 0.9 https://infectiouscongress.com/program/scientific-sessions/hookworms 0.9 https://infectiouscongress.com/program/scientific-sessions/host-pathogen-interactions 0.9 https://infectiouscongress.com/program/scientific-sessions/hpv-human-papillomavirus 0.9 https://infectiouscongress.com/program/scientific-sessions/human-immuno-deficiency-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/human-papilloma-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/human-virus-interactions 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/influenza-a 0.9 https://infectiouscongress.com/program/scientific-sessions/influenza-b 0.9 https://infectiouscongress.com/program/scientific-sessions/intestinal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/intra-abdominal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/intravascular-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/invasive-meningococcal-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/isospora-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/japanese-encephalitis-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/joint-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/legionella-bacteria 0.9 https://infectiouscongress.com/program/scientific-sessions/leprosy 0.9 https://infectiouscongress.com/program/scientific-sessions/liver-fluke-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/lower-respiratory-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/lung-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/lysogenic-viruses 0.9 https://infectiouscongress.com/program/scientific-sessions/lytic-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/measles 0.9 https://infectiouscongress.com/program/scientific-sessions/meningitis-infection 0.9 https://infectiouscongress.com/program/scientific-sessions/mumps 0.9 https://infectiouscongress.com/program/scientific-sessions/musculoskeletal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/mycobacterial-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/neuroinfectious-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/nipah-virus-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/ocular-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/papillomavirus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/parasitic-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/perinatal-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/pilus-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/pinworm-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/plague 0.9 https://infectiouscongress.com/program/scientific-sessions/pneumococcal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/protozoal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/protozoan-vaccines 0.9 https://infectiouscongress.com/program/scientific-sessions/pseudoterranova-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/pulmonary-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/reovirus 0.9 https://infectiouscongress.com/program/scientific-sessions/respiratory-tract-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/retroviral-proteins 0.9 https://infectiouscongress.com/program/scientific-sessions/rotavirus 0.9 https://infectiouscongress.com/program/scientific-sessions/roundworm-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/rubella 0.9 https://infectiouscongress.com/program/scientific-sessions/salmonella-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/scarlet-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/shigella-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/sinusitis 0.9 https://infectiouscongress.com/program/scientific-sessions/smallpox 0.9 https://infectiouscongress.com/program/scientific-sessions/staphylococcal-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/surgical-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/swine-flu 0.9 https://infectiouscongress.com/program/scientific-sessions/tapeworm-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/tetanus 0.9 https://infectiouscongress.com/program/scientific-sessions/tick-bite-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/tuberculosis 0.9 https://infectiouscongress.com/program/scientific-sessions/tumor-viral-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/typhus-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/upper-respiratory-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/urinary-tract-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/vaccine-preventable-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/vaginal-candidiasis 0.9 https://infectiouscongress.com/program/scientific-sessions/valley-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/varicella-zoster-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/vector-borne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-hepatites 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-load 0.9 https://infectiouscongress.com/program/scientific-sessions/virus-replication 0.9 https://infectiouscongress.com/program/scientific-sessions/west-nile-fever 0.9 https://infectiouscongress.com/program/scientific-sessions/wound-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/zika-virus 0.9 https://infectiouscongress.com/program/scientific-sessions/zoonotic-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/anti-infective-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/anti-infective-therapy 0.9 https://infectiouscongress.com/program/scientific-sessions/antibacterial-drug 0.9 https://infectiouscongress.com/program/scientific-sessions/antibiotic-discovery 0.9 https://infectiouscongress.com/program/scientific-sessions/antibiotic-sensitivity 0.9 https://infectiouscongress.com/program/scientific-sessions/antifungal-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/antifungal-resistance 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-agents 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-chemotherapy 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-drug-resistance 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-drugs 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-peptides 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-prophylaxis 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-stewardship 0.9 https://infectiouscongress.com/program/scientific-sessions/antiparasitic-agent 0.9 https://infectiouscongress.com/program/scientific-sessions/antiparasitic-drugs 0.9 https://infectiouscongress.com/program/scientific-sessions/antiretrovirals 0.9 https://infectiouscongress.com/program/scientific-sessions/antiviral-research 0.9 https://infectiouscongress.com/program/scientific-sessions/applied-microbiology 0.9 https://infectiouscongress.com/program/scientific-sessions/bacterial-cell-biophysics 0.9 https://infectiouscongress.com/program/scientific-sessions/bacteriostatic-agent 0.9 https://infectiouscongress.com/program/scientific-sessions/beneficial-microbes 0.9 https://infectiouscongress.com/program/scientific-sessions/beta-lactam-antibiotics 0.9 https://infectiouscongress.com/program/scientific-sessions/broad-spectrum-antibiotic 0.9 https://infectiouscongress.com/program/scientific-sessions/diagnostic-microbiology 0.9 https://infectiouscongress.com/program/scientific-sessions/disinfectants 0.9 https://infectiouscongress.com/program/scientific-sessions/environmental-microbiology 0.9 https://infectiouscongress.com/program/scientific-sessions/eukaryotic-cell 0.9 https://infectiouscongress.com/program/scientific-sessions/genome-research 0.9 https://infectiouscongress.com/program/scientific-sessions/macrolides 0.9 https://infectiouscongress.com/program/scientific-sessions/microbial-biogeochemistry 0.9 https://infectiouscongress.com/program/scientific-sessions/microbial-sciences 0.9 https://infectiouscongress.com/program/scientific-sessions/microbiological-research 0.9 https://infectiouscongress.com/program/scientific-sessions/microbiology-and-immunology 0.9 https://infectiouscongress.com/program/scientific-sessions/microbiology-spectrum 0.9 https://infectiouscongress.com/program/scientific-sessions/microorganisms 0.9 https://infectiouscongress.com/program/scientific-sessions/molecular-biology 0.9 https://infectiouscongress.com/program/scientific-sessions/multidrug-resistance 0.9 https://infectiouscongress.com/program/scientific-sessions/novel-antimicrobials 0.9 https://infectiouscongress.com/program/scientific-sessions/soil-microbiology 0.9 https://infectiouscongress.com/program/scientific-sessions/superbugs-and-superdrugs 0.9 https://infectiouscongress.com/program/scientific-sessions/therapeutic-drug-monitoring 0.9 https://infectiouscongress.com/program/scientific-sessions/vaccines-and-immunology 0.9 https://infectiouscongress.com/program/scientific-sessions/airborne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/angiostrongyliasis 0.9 https://infectiouscongress.com/program/scientific-sessions/antibiotic-research 0.9 https://infectiouscongress.com/program/scientific-sessions/antibiotic-stewardship 0.9 https://infectiouscongress.com/program/scientific-sessions/antiviral-therapies 0.9 https://infectiouscongress.com/program/scientific-sessions/arthropod-borne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/aspergillosis 0.9 https://infectiouscongress.com/program/scientific-sessions/bacteriology 0.9 https://infectiouscongress.com/program/scientific-sessions/brucellosis 0.9 https://infectiouscongress.com/program/scientific-sessions/chagas-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/climate-change-and-microbial-threats 0.9 https://infectiouscongress.com/program/scientific-sessions/clinical-and-applied-microbiology 0.9 https://infectiouscongress.com/program/scientific-sessions/clostridioides-difficile 0.9 https://infectiouscongress.com/program/scientific-sessions/drug-discovery-and-development-for-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/emerging-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/evolutionary-genetics-of-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/foodborne-illness 0.9 https://infectiouscongress.com/program/scientific-sessions/hansens-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/healthcare-associated-infections 0.9 https://infectiouscongress.com/program/scientific-sessions/hib-disease 0.9 https://infectiouscongress.com/program/scientific-sessions/hiv-aids 0.9 https://infectiouscongress.com/program/scientific-sessions/immunization 0.9 https://infectiouscongress.com/program/scientific-sessions/immunocompromised-host 0.9 https://infectiouscongress.com/program/scientific-sessions/immunotherapy-for-infectious-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-disease-and-molecular-diagnostics 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-disease-epidemiology 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-disease-modelling 0.9 https://infectiouscongress.com/program/scientific-sessions/malaria 0.9 https://infectiouscongress.com/program/scientific-sessions/medical-microbiology 0.9 https://infectiouscongress.com/program/scientific-sessions/meningococcus 0.9 https://infectiouscongress.com/program/scientific-sessions/microbial-biotechnology 0.9 https://infectiouscongress.com/program/scientific-sessions/microbial-ecology 0.9 https://infectiouscongress.com/program/scientific-sessions/microbial-genomics 0.9 https://infectiouscongress.com/program/scientific-sessions/microbial-pathogenesis 0.9 https://infectiouscongress.com/program/scientific-sessions/mucormycosis 0.9 https://infectiouscongress.com/program/scientific-sessions/mycology 0.9 https://infectiouscongress.com/program/scientific-sessions/one-health-approach 0.9 https://infectiouscongress.com/program/scientific-sessions/pandemic-preparedness 0.9 https://infectiouscongress.com/program/scientific-sessions/parasitic-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/personal-protection-equipment-ppe 0.9 https://infectiouscongress.com/program/scientific-sessions/schistosomiasis 0.9 https://infectiouscongress.com/program/scientific-sessions/ticks-and-tick-borne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/tuberculosis-and-other-mycobacterial-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-hepatitis 0.9 https://infectiouscongress.com/program/scientific-sessions/virology-research 0.9 https://infectiouscongress.com/program/scientific-sessions/waterborne-diseases 0.9 https://infectiouscongress.com/program/scientific-sessions/infectious-disease-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/microbiologists 0.9 https://infectiouscongress.com/program/scientific-sessions/virologists 0.9 https://infectiouscongress.com/program/scientific-sessions/bacteriologists 0.9 https://infectiouscongress.com/program/scientific-sessions/mycologists 0.9 https://infectiouscongress.com/program/scientific-sessions/parasitologists 0.9 https://infectiouscongress.com/program/scientific-sessions/epidemiologists 0.9 https://infectiouscongress.com/program/scientific-sessions/immunologists 0.9 https://infectiouscongress.com/program/scientific-sessions/tropical-medicine-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/infection-control-practitioners 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-resistance-experts 0.9 https://infectiouscongress.com/program/scientific-sessions/hospital-epidemiologists 0.9 https://infectiouscongress.com/program/scientific-sessions/vaccine-researchers 0.9 https://infectiouscongress.com/program/scientific-sessions/zoonotic-disease-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/medical-entomologists 0.9 https://infectiouscongress.com/program/scientific-sessions/nosocomial-infection-experts 0.9 https://infectiouscongress.com/program/scientific-sessions/molecular-biologists 0.9 https://infectiouscongress.com/program/scientific-sessions/biotechnologists 0.9 https://infectiouscongress.com/program/scientific-sessions/bioinformaticians 0.9 https://infectiouscongress.com/program/scientific-sessions/diagnostic-laboratory-scientists 0.9 https://infectiouscongress.com/program/scientific-sessions/tropical-disease-researchers 0.9 https://infectiouscongress.com/program/scientific-sessions/pandemic-preparedness-experts 0.9 https://infectiouscongress.com/program/scientific-sessions/antiviral-and-antibiotic-drug-developers 0.9 https://infectiouscongress.com/program/scientific-sessions/pathologists 0.9 https://infectiouscongress.com/program/scientific-sessions/infection-prevention-and-control-nurses 0.9 https://infectiouscongress.com/program/scientific-sessions/clinical-microbiologists 0.9 https://infectiouscongress.com/program/scientific-sessions/clinical-virologists 0.9 https://infectiouscongress.com/program/scientific-sessions/clinical-parasitologists 0.9 https://infectiouscongress.com/program/scientific-sessions/vector-borne-disease-experts 0.9 https://infectiouscongress.com/program/scientific-sessions/one-health-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/global-health-security-experts 0.9 https://infectiouscongress.com/program/scientific-sessions/biocontainment-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/immunopathologists 0.9 https://infectiouscongress.com/program/scientific-sessions/disease-surveillance-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/field-epidemiologists 0.9 https://infectiouscongress.com/program/scientific-sessions/antimicrobial-stewardship-coordinators 0.9 https://infectiouscongress.com/program/scientific-sessions/tropical-infectious-disease-clinicians 0.9 https://infectiouscongress.com/program/scientific-sessions/viral-hemorrhagic-fever-researchers 0.9 https://infectiouscongress.com/program/scientific-sessions/outbreak-response-coordinators 0.9 https://infectiouscongress.com/program/scientific-sessions/zoonosis-control-specialists 0.9 https://infectiouscongress.com/program/scientific-sessions/emerging-pathogen-researchers 0.9 https://infectiouscongress.com/program/scientific-sessions/contagion-modeling-experts 0.9 https://infectiouscongress.com/program/scientific-sessions/quarantine-and-isolation-policy-advisors 0.9 https://infectiouscongress.com/uploads/pdfs/abstract-submission-sample.docx 0.8 https://infectiouscongress.com/uploads/pdfs/final-program.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/tentative-program.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/initial-announcement.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/conference-brochure.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/sponsors-exhibitors.pdf 0.8 https://infectiouscongress.com/2025 0.8 https://infectiouscongress.com/uploads/pdfs/infection-2025-abstract-book.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/final-program.pdf?t=1750749034 0.8 https://infectiouscongress.com/2024 0.8 https://infectiouscongress.com/uploads/pdfs/infection-2024-abstract-book.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/infectious-diseases-2024-final-program.pdf 0.8 https://infectiouscongress.com/2023 0.8 https://infectiouscongress.com/uploads/pdfs/infectious-diseases-2023-abstract-book.pdf 0.8 https://infectiouscongress.com/uploads/pdfs/infectious-diseases-2023-final-program.pdf 0.8 https://infectiouscongress.com/2022 0.8 https://infectiouscongress.com/uploads/pdfs/infectious-diseases-2022-virtual-abstract-book.pdf 0.8 https://infectiouscongress.com/uploads/past-events/2nd-edition-of-world-congress-on-infectious-diseases-2022-program.pdf 0.8 https://infectiouscongress.com/gallery 0.8 https://infectiouscongress.com/gallery/infection-conference-2025-rome-italy 0.8 https://infectiouscongress.com/gallery/infection-conference-2024-paris-france 0.8 https://infectiouscongress.com/gallery/infection-conference-2023-rome-italy 0.8